EP1676559A2 - Cosmetic or dermatological article containing a support which is soluble in water - Google Patents
Cosmetic or dermatological article containing a support which is soluble in water Download PDFInfo
- Publication number
- EP1676559A2 EP1676559A2 EP05301104A EP05301104A EP1676559A2 EP 1676559 A2 EP1676559 A2 EP 1676559A2 EP 05301104 A EP05301104 A EP 05301104A EP 05301104 A EP05301104 A EP 05301104A EP 1676559 A2 EP1676559 A2 EP 1676559A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- cosmetic
- water
- support
- article according
- article
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 78
- 239000002537 cosmetic Substances 0.000 title claims abstract description 73
- 239000000203 mixture Substances 0.000 claims abstract description 114
- 150000001875 compounds Chemical class 0.000 claims abstract description 30
- 238000004090 dissolution Methods 0.000 claims abstract description 11
- 239000012530 fluid Substances 0.000 claims abstract description 4
- 239000000835 fiber Substances 0.000 claims description 59
- 239000000463 material Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 10
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 10
- 238000004806 packaging method and process Methods 0.000 claims description 9
- 239000000758 substrate Substances 0.000 claims description 8
- 210000004209 hair Anatomy 0.000 claims description 7
- 229920001296 polysiloxane Polymers 0.000 claims description 6
- 239000000853 adhesive Substances 0.000 claims description 5
- 230000001070 adhesive effect Effects 0.000 claims description 5
- 238000005187 foaming Methods 0.000 claims description 5
- 235000011837 pasties Nutrition 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 210000004400 mucous membrane Anatomy 0.000 claims description 4
- 102000011782 Keratins Human genes 0.000 claims description 3
- 108010076876 Keratins Proteins 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 238000005520 cutting process Methods 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000002453 shampoo Substances 0.000 claims description 2
- 238000012856 packing Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 description 30
- 239000010410 layer Substances 0.000 description 27
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 23
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 20
- 210000003491 skin Anatomy 0.000 description 19
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 18
- -1 polyethylene Polymers 0.000 description 18
- 239000000049 pigment Substances 0.000 description 17
- 229910052708 sodium Inorganic materials 0.000 description 16
- 239000011734 sodium Substances 0.000 description 16
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 14
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 12
- 239000003795 chemical substances by application Substances 0.000 description 12
- 239000003086 colorant Substances 0.000 description 12
- 229910052726 zirconium Inorganic materials 0.000 description 12
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 11
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 10
- 239000000975 dye Substances 0.000 description 10
- 229910052788 barium Inorganic materials 0.000 description 9
- 229910021653 sulphate ion Inorganic materials 0.000 description 9
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 8
- JDRSMPFHFNXQRB-IBEHDNSVSA-N decyl glucoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JDRSMPFHFNXQRB-IBEHDNSVSA-N 0.000 description 8
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 8
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 8
- PXKSAXUKRMRORY-ZWKOTPCHSA-N 2-(3,4-dichlorophenyl)-n-[(1s,2r)-2-(2,5-dihydropyrrol-1-yl)cyclohexyl]-n-methylacetamide Chemical compound N1([C@@H]2CCCC[C@@H]2N(C)C(=O)CC=2C=C(Cl)C(Cl)=CC=2)CC=CC1 PXKSAXUKRMRORY-ZWKOTPCHSA-N 0.000 description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 7
- 229910004298 SiO 2 Inorganic materials 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 239000013543 active substance Substances 0.000 description 7
- 239000011575 calcium Substances 0.000 description 7
- 229910052791 calcium Inorganic materials 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 7
- 229910052737 gold Inorganic materials 0.000 description 7
- 239000010931 gold Substances 0.000 description 7
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 6
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 6
- 206010040844 Skin exfoliation Diseases 0.000 description 6
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 6
- 125000000217 alkyl group Chemical group 0.000 description 6
- 150000002430 hydrocarbons Chemical class 0.000 description 6
- 239000010445 mica Substances 0.000 description 6
- 229910052618 mica group Inorganic materials 0.000 description 6
- ZYIBVBKZZZDFOY-UHFFFAOYSA-N phloxine O Chemical compound O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 ZYIBVBKZZZDFOY-UHFFFAOYSA-N 0.000 description 6
- 230000007928 solubilization Effects 0.000 description 6
- 238000005063 solubilization Methods 0.000 description 6
- 229910052712 strontium Inorganic materials 0.000 description 6
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 6
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 5
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 5
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 239000006260 foam Substances 0.000 description 5
- 229930195733 hydrocarbon Natural products 0.000 description 5
- 238000005470 impregnation Methods 0.000 description 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000012860 organic pigment Substances 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- 229960004889 salicylic acid Drugs 0.000 description 5
- 210000000434 stratum corneum Anatomy 0.000 description 5
- 229910052719 titanium Inorganic materials 0.000 description 5
- 239000010936 titanium Substances 0.000 description 5
- IJFXRHURBJZNAO-UHFFFAOYSA-N 3-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1 IJFXRHURBJZNAO-UHFFFAOYSA-N 0.000 description 4
- 229910000906 Bronze Inorganic materials 0.000 description 4
- 239000004215 Carbon black (E152) Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 229910010413 TiO 2 Inorganic materials 0.000 description 4
- 239000010974 bronze Substances 0.000 description 4
- 230000035618 desquamation Effects 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 229940047642 disodium cocoamphodiacetate Drugs 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 235000013980 iron oxide Nutrition 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 229910052709 silver Inorganic materials 0.000 description 4
- 239000004332 silver Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 3
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 3
- IXIGWKNBFPKCCD-UHFFFAOYSA-N 2-hydroxy-5-octanoylbenzoic acid Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 IXIGWKNBFPKCCD-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 3
- 239000004342 Benzoyl peroxide Substances 0.000 description 3
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 239000004599 antimicrobial Substances 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 235000019400 benzoyl peroxide Nutrition 0.000 description 3
- 238000003490 calendering Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 3
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 3
- 239000004922 lacquer Substances 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 3
- 239000000419 plant extract Substances 0.000 description 3
- 229920000058 polyacrylate Polymers 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229940057950 sodium laureth sulfate Drugs 0.000 description 3
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- SRQZUAPSTKOCBW-UHFFFAOYSA-N 1-dodecanoylpyrrolidin-2-one Chemical compound CCCCCCCCCCCC(=O)N1CCCC1=O SRQZUAPSTKOCBW-UHFFFAOYSA-N 0.000 description 2
- OAAZUWWNSYWWHG-UHFFFAOYSA-N 1-phenoxypropan-1-ol Chemical compound CCC(O)OC1=CC=CC=C1 OAAZUWWNSYWWHG-UHFFFAOYSA-N 0.000 description 2
- IBLKWZIFZMJLFL-UHFFFAOYSA-N 1-phenoxypropan-2-ol Chemical compound CC(O)COC1=CC=CC=C1 IBLKWZIFZMJLFL-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- QTDIEDOANJISNP-UHFFFAOYSA-N 2-dodecoxyethyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOCCOS(O)(=O)=O QTDIEDOANJISNP-UHFFFAOYSA-N 0.000 description 2
- AFENDNXGAFYKQO-UHFFFAOYSA-N 2-hydroxybutyric acid Chemical compound CCC(O)C(O)=O AFENDNXGAFYKQO-UHFFFAOYSA-N 0.000 description 2
- NYHNVHGFPZAZGA-UHFFFAOYSA-N 2-hydroxyhexanoic acid Chemical compound CCCCC(O)C(O)=O NYHNVHGFPZAZGA-UHFFFAOYSA-N 0.000 description 2
- JRHWHSJDIILJAT-UHFFFAOYSA-N 2-hydroxypentanoic acid Chemical compound CCCC(O)C(O)=O JRHWHSJDIILJAT-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- DSVUBXQDJGJGIC-UHFFFAOYSA-N 3',6'-dihydroxy-4',5'-diiodospiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C(I)=C1OC1=C(I)C(O)=CC=C21 DSVUBXQDJGJGIC-UHFFFAOYSA-N 0.000 description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 2
- MSTDXOZUKAQDRL-UHFFFAOYSA-N 4-Chromanone Chemical compound C1=CC=C2C(=O)CCOC2=C1 MSTDXOZUKAQDRL-UHFFFAOYSA-N 0.000 description 2
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 2
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 2
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 2
- JDRSMPFHFNXQRB-CMTNHCDUSA-N Decyl beta-D-threo-hexopyranoside Chemical compound CCCCCCCCCCO[C@@H]1O[C@H](CO)C(O)[C@H](O)C1O JDRSMPFHFNXQRB-CMTNHCDUSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 2
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 2
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- RSYYQCDERUOEFI-JTQLQIEISA-N N-benzoyl-L-arginine Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)C1=CC=CC=C1 RSYYQCDERUOEFI-JTQLQIEISA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 229920000299 Nylon 12 Polymers 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 244000184734 Pyrus japonica Species 0.000 description 2
- 108010077895 Sarcosine Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FHNINJWBTRXEBC-UHFFFAOYSA-N Sudan III Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC(C=C1)=CC=C1N=NC1=CC=CC=C1 FHNINJWBTRXEBC-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 2
- 150000004056 anthraquinones Chemical class 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 235000012730 carminic acid Nutrition 0.000 description 2
- ZLWLTDZLUVBSRJ-UHFFFAOYSA-K chembl2360149 Chemical compound [Na+].[Na+].[Na+].O=C1C(N=NC=2C=CC(=CC=2)S([O-])(=O)=O)=C(C(=O)[O-])NN1C1=CC=C(S([O-])(=O)=O)C=C1 ZLWLTDZLUVBSRJ-UHFFFAOYSA-K 0.000 description 2
- 229960003260 chlorhexidine Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 229940086624 d&c orange no. 10 Drugs 0.000 description 2
- 229940075493 d&c red no. 6 Drugs 0.000 description 2
- 229940073499 decyl glucoside Drugs 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 2
- LQJVOKWHGUAUHK-UHFFFAOYSA-L disodium 5-amino-4-hydroxy-3-phenyldiazenylnaphthalene-2,7-disulfonate Chemical compound [Na+].[Na+].OC1=C2C(N)=CC(S([O-])(=O)=O)=CC2=CC(S([O-])(=O)=O)=C1N=NC1=CC=CC=C1 LQJVOKWHGUAUHK-UHFFFAOYSA-L 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- AEUTYOVWOVBAKS-UWVGGRQHSA-N ethambutol Chemical compound CC[C@@H](CO)NCCN[C@@H](CC)CO AEUTYOVWOVBAKS-UWVGGRQHSA-N 0.000 description 2
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 2
- 238000004299 exfoliation Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- FWQHNLCNFPYBCA-UHFFFAOYSA-N fluoran Chemical compound C12=CC=CC=C2OC2=CC=CC=C2C11OC(=O)C2=CC=CC=C21 FWQHNLCNFPYBCA-UHFFFAOYSA-N 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 229960004275 glycolic acid Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 229940097275 indigo Drugs 0.000 description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940100554 isononyl isononanoate Drugs 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 229960000448 lactic acid Drugs 0.000 description 2
- PYIDGJJWBIBVIA-UYTYNIKBSA-N lauryl glucoside Chemical compound CCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PYIDGJJWBIBVIA-UYTYNIKBSA-N 0.000 description 2
- 229940048848 lauryl glucoside Drugs 0.000 description 2
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000015250 liver sausages Nutrition 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- OAIQHKWDTQYGOK-UHFFFAOYSA-L magnesium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Mg+2].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O.CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O OAIQHKWDTQYGOK-UHFFFAOYSA-L 0.000 description 2
- 229960002160 maltose Drugs 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000011049 pearl Substances 0.000 description 2
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 2
- LOQGSOTUHASIHI-UHFFFAOYSA-N perfluoro-1,3-dimethylcyclohexane Chemical compound FC(F)(F)C1(F)C(F)(F)C(F)(F)C(F)(F)C(F)(C(F)(F)F)C1(F)F LOQGSOTUHASIHI-UHFFFAOYSA-N 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 229940106026 phenoxyisopropanol Drugs 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- GVKCHTBDSMQENH-UHFFFAOYSA-L phloxine B Chemical compound [Na+].[Na+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 GVKCHTBDSMQENH-UHFFFAOYSA-L 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 229950001046 piroctone Drugs 0.000 description 2
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 description 2
- 229940116406 poloxamer 184 Drugs 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- XYSQXZCMOLNHOI-UHFFFAOYSA-N s-[2-[[4-(acetylsulfamoyl)phenyl]carbamoyl]phenyl] 5-pyridin-1-ium-1-ylpentanethioate;bromide Chemical compound [Br-].C1=CC(S(=O)(=O)NC(=O)C)=CC=C1NC(=O)C1=CC=CC=C1SC(=O)CCCC[N+]1=CC=CC=C1 XYSQXZCMOLNHOI-UHFFFAOYSA-N 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000009958 sewing Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002910 solid waste Substances 0.000 description 2
- 239000002195 soluble material Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- AAAQKTZKLRYKHR-UHFFFAOYSA-N triphenylmethane Chemical compound C1=CC=CC=C1C(C=1C=CC=CC=1)C1=CC=CC=C1 AAAQKTZKLRYKHR-UHFFFAOYSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- 235000014692 zinc oxide Nutrition 0.000 description 2
- 229940043810 zinc pyrithione Drugs 0.000 description 2
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- NDDLLTAIKYHPOD-ISLYRVAYSA-N (2e)-6-chloro-2-(6-chloro-4-methyl-3-oxo-1-benzothiophen-2-ylidene)-4-methyl-1-benzothiophen-3-one Chemical compound S/1C2=CC(Cl)=CC(C)=C2C(=O)C\1=C1/SC(C=C(Cl)C=C2C)=C2C1=O NDDLLTAIKYHPOD-ISLYRVAYSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- BMLMGCPTLHPWPY-REOHCLBHSA-N (4R)-2-oxo-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSC(=O)N1 BMLMGCPTLHPWPY-REOHCLBHSA-N 0.000 description 1
- XIYOPDCBBDCGOE-IWVLMIASSA-N (4s,4ar,5s,5ar,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methylidene-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C=C1C2=CC=CC(O)=C2C(O)=C2[C@@H]1[C@H](O)[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O XIYOPDCBBDCGOE-IWVLMIASSA-N 0.000 description 1
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- FFTVPQUHLQBXQZ-KVUCHLLUSA-N (4s,4as,5ar,12ar)-4,7-bis(dimethylamino)-1,10,11,12a-tetrahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1C2=C(N(C)C)C=CC(O)=C2C(O)=C2[C@@H]1C[C@H]1[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]1(O)C2=O FFTVPQUHLQBXQZ-KVUCHLLUSA-N 0.000 description 1
- KAKVFSYQVNHFBS-UHFFFAOYSA-N (5-hydroxycyclopenten-1-yl)-phenylmethanone Chemical compound OC1CCC=C1C(=O)C1=CC=CC=C1 KAKVFSYQVNHFBS-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- BCNXQFASJTYKDJ-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,5-nonafluoro-5-(trifluoromethyl)cyclopentane Chemical compound FC(F)(F)C1(F)C(F)(F)C(F)(F)C(F)(F)C1(F)F BCNXQFASJTYKDJ-UHFFFAOYSA-N 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- XLTMWFMRJZDFFD-UHFFFAOYSA-N 1-[(2-chloro-4-nitrophenyl)diazenyl]naphthalen-2-ol Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C([N+]([O-])=O)C=C1Cl XLTMWFMRJZDFFD-UHFFFAOYSA-N 0.000 description 1
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 1
- RWKSBJVOQGKDFZ-UHFFFAOYSA-N 16-methylheptadecyl 2-hydroxypropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)O RWKSBJVOQGKDFZ-UHFFFAOYSA-N 0.000 description 1
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
- DJXPNUIRGNRCPQ-UHFFFAOYSA-N 2-[2,3-bis[2-(16-methylheptadecanoyloxy)ethoxy]propoxy]ethyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCOCC(COCCOC(=O)CCCCCCCCCCCCCCC(C)C)OCCOC(=O)CCCCCCCCCCCCCCC(C)C DJXPNUIRGNRCPQ-UHFFFAOYSA-N 0.000 description 1
- FWIUBOWVXREPPL-UHFFFAOYSA-N 2-[2-(7-methyloctanoyloxy)ethoxy]ethyl 7-methyloctanoate Chemical compound CC(C)CCCCCC(=O)OCCOCCOC(=O)CCCCCC(C)C FWIUBOWVXREPPL-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 1
- XULHFMYCBKQGEE-UHFFFAOYSA-N 2-hexyl-1-Decanol Chemical compound CCCCCCCCC(CO)CCCCCC XULHFMYCBKQGEE-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BMLMGCPTLHPWPY-UHFFFAOYSA-N 2-oxo-1,3-thiazolidine-4-carboxylic acid Chemical class OC(=O)C1CSC(=O)N1 BMLMGCPTLHPWPY-UHFFFAOYSA-N 0.000 description 1
- PWUSHZPXYOALFZ-UHFFFAOYSA-N 3-hydroxy-4-[(1-sulfonaphthalen-2-yl)diazenyl]naphthalene-2-carboxylic acid Chemical compound OC(=O)c1cc2ccccc2c(N=Nc2ccc3ccccc3c2S(O)(=O)=O)c1O PWUSHZPXYOALFZ-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- ZDTNHRWWURISAA-UHFFFAOYSA-N 4',5'-dibromo-3',6'-dihydroxyspiro[2-benzofuran-3,9'-xanthene]-1-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C(Br)=C1OC1=C(Br)C(O)=CC=C21 ZDTNHRWWURISAA-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- NSWKKBKROCMOHA-UHFFFAOYSA-N 4-(naphthalen-1-yldiazenyl)naphthalen-1-ol Chemical compound Oc1ccc(N=Nc2cccc3ccccc23)c2ccccc12 NSWKKBKROCMOHA-UHFFFAOYSA-N 0.000 description 1
- OSDLLIBGSJNGJE-UHFFFAOYSA-N 4-chloro-3,5-dimethylphenol Chemical compound CC1=CC(O)=CC(C)=C1Cl OSDLLIBGSJNGJE-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 240000000972 Agathis dammara Species 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- FXALIOUHXMVTMJ-UHFFFAOYSA-N CCCCCCCCCCCC([Na])=O Chemical compound CCCCCCCCCCCC([Na])=O FXALIOUHXMVTMJ-UHFFFAOYSA-N 0.000 description 1
- 208000031968 Cadaver Diseases 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 240000005209 Canarium indicum Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102100025566 Chymotrypsin-like protease CTRL-1 Human genes 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 239000004859 Copal Substances 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 229920002871 Dammar gum Polymers 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 241000782205 Guibourtia conjugata Species 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 241000258937 Hemiptera Species 0.000 description 1
- 101000856199 Homo sapiens Chymotrypsin-like protease CTRL-1 Proteins 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- OWYWGLHRNBIFJP-UHFFFAOYSA-N Ipazine Chemical compound CCN(CC)C1=NC(Cl)=NC(NC(C)C)=N1 OWYWGLHRNBIFJP-UHFFFAOYSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 102100034867 Kallikrein-7 Human genes 0.000 description 1
- 101710176222 Kallikrein-7 Proteins 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- QIAFMBKCNZACKA-UHFFFAOYSA-N N-benzoylglycine Chemical compound OC(=O)CNC(=O)C1=CC=CC=C1 QIAFMBKCNZACKA-UHFFFAOYSA-N 0.000 description 1
- SAVLIIGUQOSOEP-UHFFFAOYSA-N N-octanoylglycine Chemical compound CCCCCCCC(=O)NCC(O)=O SAVLIIGUQOSOEP-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004100 Oxytetracycline Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- UOZODPSAJZTQNH-UHFFFAOYSA-N Paromomycin II Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)CC(N)C2O)OC2C(C(O)C(O)C(CO)O2)N)OC1CO UOZODPSAJZTQNH-UHFFFAOYSA-N 0.000 description 1
- SJEYSFABYSGQBG-UHFFFAOYSA-M Patent blue Chemical compound [Na+].C1=CC(N(CC)CC)=CC=C1C(C=1C(=CC(=CC=1)S([O-])(=O)=O)S([O-])(=O)=O)=C1C=CC(=[N+](CC)CC)C=C1 SJEYSFABYSGQBG-UHFFFAOYSA-M 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 241001080024 Telles Species 0.000 description 1
- 241000736873 Tetraclinis articulata Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- CQPFMGBJSMSXLP-UHFFFAOYSA-M acid orange 7 Chemical compound [Na+].OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 CQPFMGBJSMSXLP-UHFFFAOYSA-M 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000003113 alkalizing effect Effects 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 150000001371 alpha-amino acids Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- CSJKPFQJIDMSGF-UHFFFAOYSA-K aluminum;tribenzoate Chemical compound [Al+3].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 CSJKPFQJIDMSGF-UHFFFAOYSA-K 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000002225 anti-radical effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- UHHXUPJJDHEMGX-UHFFFAOYSA-K azanium;manganese(3+);phosphonato phosphate Chemical compound [NH4+].[Mn+3].[O-]P([O-])(=O)OP([O-])([O-])=O UHHXUPJJDHEMGX-UHFFFAOYSA-K 0.000 description 1
- 229960002255 azelaic acid Drugs 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000015191 beet juice Nutrition 0.000 description 1
- OHXVIZBSLGZEFS-UHFFFAOYSA-N benzhydrylsilyloxy-diphenyl-silyloxysilane Chemical class C1(=CC=CC=C1)C(C1=CC=CC=C1)[SiH2]O[Si](O[SiH3])(C1=CC=CC=C1)C1=CC=CC=C1 OHXVIZBSLGZEFS-UHFFFAOYSA-N 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 239000004161 brilliant blue FCF Substances 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- DBZJJPROPLPMSN-UHFFFAOYSA-N bromoeosin Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C(O)C(Br)=C1OC1=C(Br)C(O)=C(Br)C=C21 DBZJJPROPLPMSN-UHFFFAOYSA-N 0.000 description 1
- 229940067573 brown iron oxide Drugs 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- CYHOWEBNQPOWEI-UHFFFAOYSA-L calcium 3-carboxy-1-phenyldiazenylnaphthalen-2-olate Chemical compound OC=1C(=CC2=CC=CC=C2C1N=NC1=CC=CC=C1)C(=O)[O-].OC=1C(=CC2=CC=CC=C2C1N=NC1=CC=CC=C1)C(=O)[O-].[Ca+2] CYHOWEBNQPOWEI-UHFFFAOYSA-L 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 229940051368 capryloyl glycine Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000009960 carding Methods 0.000 description 1
- 239000004106 carminic acid Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 1
- 229940073669 ceteareth 20 Drugs 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 description 1
- HBHZKFOUIUMKHV-UHFFFAOYSA-N chembl1982121 Chemical compound OC1=CC=C2C=CC=CC2=C1N=NC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O HBHZKFOUIUMKHV-UHFFFAOYSA-N 0.000 description 1
- PZTQVMXMKVTIRC-UHFFFAOYSA-L chembl2028348 Chemical compound [Ca+2].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 PZTQVMXMKVTIRC-UHFFFAOYSA-L 0.000 description 1
- ONTQJDKFANPPKK-UHFFFAOYSA-L chembl3185981 Chemical compound [Na+].[Na+].CC1=CC(C)=C(S([O-])(=O)=O)C=C1N=NC1=CC(S([O-])(=O)=O)=C(C=CC=C2)C2=C1O ONTQJDKFANPPKK-UHFFFAOYSA-L 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- UOUJSJZBMCDAEU-UHFFFAOYSA-N chromium(3+);oxygen(2-) Chemical class [O-2].[O-2].[O-2].[Cr+3].[Cr+3] UOUJSJZBMCDAEU-UHFFFAOYSA-N 0.000 description 1
- QFSKIUZTIHBWFR-UHFFFAOYSA-N chromium;hydrate Chemical compound O.[Cr] QFSKIUZTIHBWFR-UHFFFAOYSA-N 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 229940080423 cochineal Drugs 0.000 description 1
- 229940080421 coco glucoside Drugs 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical class C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
- 150000005676 cyclic carbonates Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229940075482 d & c green 5 Drugs 0.000 description 1
- 229940075479 d & c red no. 27 Drugs 0.000 description 1
- 229940099441 d&c blue no. 4 Drugs 0.000 description 1
- 229940106008 d&c brown no. 1 Drugs 0.000 description 1
- 229940099449 d&c orange no. 4 Drugs 0.000 description 1
- 229940090962 d&c orange no. 5 Drugs 0.000 description 1
- 229940058010 d&c red no. 21 Drugs 0.000 description 1
- 229940056316 d&c red no. 28 Drugs 0.000 description 1
- 229940075484 d&c red no. 30 Drugs 0.000 description 1
- 229940047180 d&c red no. 34 Drugs 0.000 description 1
- 229940057946 d&c red no. 7 Drugs 0.000 description 1
- 229940096890 d&c violet no. 2 Drugs 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000001982 diacylglycerols Chemical class 0.000 description 1
- TVCBMJCHKADLEE-UHFFFAOYSA-N diazanium;2-[[4-[ethyl-[(4-sulfonatophenyl)methyl]amino]phenyl]-[4-[ethyl-[(4-sulfonatophenyl)methyl]azaniumylidene]cyclohexa-2,5-dien-1-ylidene]methyl]benzenesulfonate Chemical compound [NH4+].[NH4+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=CC(=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=C(S([O-])(=O)=O)C=C1 TVCBMJCHKADLEE-UHFFFAOYSA-N 0.000 description 1
- IMZFSONSIHHFAR-UHFFFAOYSA-L dichloroaluminum;hydrate Chemical compound O.Cl[Al]Cl IMZFSONSIHHFAR-UHFFFAOYSA-L 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- RAGZEDHHTPQLAI-UHFFFAOYSA-L disodium;2',4',5',7'-tetraiodo-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate Chemical compound [Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C([O-])C(I)=C1OC1=C(I)C([O-])=C(I)C=C21 RAGZEDHHTPQLAI-UHFFFAOYSA-L 0.000 description 1
- AHSJNHONMVUMLK-UHFFFAOYSA-L disodium;4',5'-diiodo-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate Chemical compound [Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC=C([O-])C(I)=C1OC1=C(I)C([O-])=CC=C21 AHSJNHONMVUMLK-UHFFFAOYSA-L 0.000 description 1
- FPAYXBWMYIMERV-UHFFFAOYSA-L disodium;5-methyl-2-[[4-(4-methyl-2-sulfonatoanilino)-9,10-dioxoanthracen-1-yl]amino]benzenesulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1S([O-])(=O)=O FPAYXBWMYIMERV-UHFFFAOYSA-L 0.000 description 1
- 229940102552 disteardimonium hectorite Drugs 0.000 description 1
- 229950010592 dodecafluoropentane Drugs 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- WQXNXVUDBPYKBA-YFKPBYRVSA-N ectoine Chemical compound CC1=[NH+][C@H](C([O-])=O)CCN1 WQXNXVUDBPYKBA-YFKPBYRVSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229940082150 encore Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 1
- 229940057841 eosine yellowish Drugs 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 229950000206 estolate Drugs 0.000 description 1
- 229960000285 ethambutol Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- OUDSFQBUEBFSPS-UHFFFAOYSA-N ethylenediaminetriacetic acid Chemical compound OC(=O)CNCCN(CC(O)=O)CC(O)=O OUDSFQBUEBFSPS-UHFFFAOYSA-N 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 229940057941 fd &c yellow #6 aluminum lake Drugs 0.000 description 1
- 229940083280 fd&c blue #1 aluminum lake Drugs 0.000 description 1
- 229940078737 fd&c yellow #5 aluminum lake Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 125000003900 glycosphingolipid group Chemical group 0.000 description 1
- 150000002339 glycosphingolipids Chemical class 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 1
- 229960001915 hexamidine Drugs 0.000 description 1
- OQLKNTOKMBVBKV-UHFFFAOYSA-N hexamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1 OQLKNTOKMBVBKV-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- YODZNEIDVLFIIC-UHFFFAOYSA-N icosan-10-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(CCCCCCCCC)CCCCCCCCCC YODZNEIDVLFIIC-UHFFFAOYSA-N 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 235000010187 litholrubine BK Nutrition 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
- 229940042016 methacycline Drugs 0.000 description 1
- 229960004011 methenamine Drugs 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229960000808 netilmicin Drugs 0.000 description 1
- ZBGPYVZLYBDXKO-HILBYHGXSA-N netilmycin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@]([C@H](NC)[C@@H](O)CO1)(C)O)NCC)[C@H]1OC(CN)=CC[C@H]1N ZBGPYVZLYBDXKO-HILBYHGXSA-N 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 239000011022 opal Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- 229960000625 oxytetracycline Drugs 0.000 description 1
- IWVCMVBTMGNXQD-PXOLEDIWSA-N oxytetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3[C@H](O)[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-PXOLEDIWSA-N 0.000 description 1
- 235000019366 oxytetracycline Nutrition 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- UOZODPSAJZTQNH-LSWIJEOBSA-N paromomycin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO UOZODPSAJZTQNH-LSWIJEOBSA-N 0.000 description 1
- 229960001914 paromomycin Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical class OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- XDRYMKDFEDOLFX-UHFFFAOYSA-N pentamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCOC1=CC=C(C(N)=N)C=C1 XDRYMKDFEDOLFX-UHFFFAOYSA-N 0.000 description 1
- 229960004448 pentamidine Drugs 0.000 description 1
- 229960004624 perflexane Drugs 0.000 description 1
- ZJIJAJXFLBMLCK-UHFFFAOYSA-N perfluorohexane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F ZJIJAJXFLBMLCK-UHFFFAOYSA-N 0.000 description 1
- NJCBUSHGCBERSK-UHFFFAOYSA-N perfluoropentane Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F NJCBUSHGCBERSK-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001921 poly-methyl-phenyl-siloxane Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- PYJBVGYZXWPIKK-UHFFFAOYSA-M potassium;tetradecanoate Chemical compound [K+].CCCCCCCCCCCCCC([O-])=O PYJBVGYZXWPIKK-UHFFFAOYSA-M 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229940043131 pyroglutamate Drugs 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- TVRGPOFMYCMNRB-UHFFFAOYSA-N quinizarine green ss Chemical compound C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1 TVRGPOFMYCMNRB-UHFFFAOYSA-N 0.000 description 1
- IZMJMCDDWKSTTK-UHFFFAOYSA-N quinoline yellow Chemical compound C1=CC=CC2=NC(C3C(C4=CC=CC=C4C3=O)=O)=CC=C21 IZMJMCDDWKSTTK-UHFFFAOYSA-N 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- JNMWHTHYDQTDQZ-UHFFFAOYSA-N selenium sulfide Chemical compound S=[Se]=S JNMWHTHYDQTDQZ-UHFFFAOYSA-N 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229940079776 sodium cocoyl isethionate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045875 sodium pidolate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229940048098 sodium sarcosinate Drugs 0.000 description 1
- CRPCXAMJWCDHFM-DFWYDOINSA-M sodium;(2s)-5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)[C@@H]1CCC(=O)N1 CRPCXAMJWCDHFM-DFWYDOINSA-M 0.000 description 1
- AXMCIYLNKNGNOT-UHFFFAOYSA-N sodium;3-[[4-[(4-dimethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)-[4-[ethyl-[(3-sulfophenyl)methyl]amino]phenyl]methyl]-n-ethylanilino]methyl]benzenesulfonate Chemical compound [Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](C)C)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S(O)(=O)=O)=C1 AXMCIYLNKNGNOT-UHFFFAOYSA-N 0.000 description 1
- VRDAELYOGRCZQD-NFLRKZIHSA-M sodium;4-[(2z)-2-[(5e)-5-[(2,4-dimethylphenyl)hydrazinylidene]-4,6-dioxocyclohex-2-en-1-ylidene]hydrazinyl]benzenesulfonate Chemical compound [Na+].CC1=CC(C)=CC=C1N\N=C(/C(=O)C=C\1)C(=O)C/1=N\NC1=CC=C(S([O-])(=O)=O)C=C1 VRDAELYOGRCZQD-NFLRKZIHSA-M 0.000 description 1
- HSFQBFMEWSTNOW-UHFFFAOYSA-N sodium;carbanide Chemical group [CH3-].[Na+] HSFQBFMEWSTNOW-UHFFFAOYSA-N 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- LJFWQNJLLOFIJK-UHFFFAOYSA-N solvent violet 13 Chemical compound C1=CC(C)=CC=C1NC1=CC=C(O)C2=C1C(=O)C1=CC=CC=C1C2=O LJFWQNJLLOFIJK-UHFFFAOYSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 229940099373 sudan iii Drugs 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 150000003463 sulfur Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000707 tobramycin Drugs 0.000 description 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
- 229960004880 tolnaftate Drugs 0.000 description 1
- FUSNMLFNXJSCDI-UHFFFAOYSA-N tolnaftate Chemical compound C=1C=C2C=CC=CC2=CC=1OC(=S)N(C)C1=CC=CC(C)=C1 FUSNMLFNXJSCDI-UHFFFAOYSA-N 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- COXJMKGEQAWXNP-UHFFFAOYSA-N tris(14-methylpentadecyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCCCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCCCCCCCC(C)C)CC(=O)OCCCCCCCCCCCCCC(C)C COXJMKGEQAWXNP-UHFFFAOYSA-N 0.000 description 1
- OHOTVSOGTVKXEL-UHFFFAOYSA-K trisodium;2-[bis(carboxylatomethyl)amino]propanoate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C(C)N(CC([O-])=O)CC([O-])=O OHOTVSOGTVKXEL-UHFFFAOYSA-K 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229920006163 vinyl copolymer Polymers 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
- RNWHGQJWIACOKP-UHFFFAOYSA-N zinc;oxygen(2-) Chemical class [O-2].[Zn+2] RNWHGQJWIACOKP-UHFFFAOYSA-N 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8129—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/14—Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q9/00—Preparations for removing hair or for aiding hair removal
- A61Q9/02—Shaving preparations
Definitions
- the present invention relates, in particular, to cosmetic or dermatological articles comprising at least one support and at least one cosmetic composition carried by the support.
- Articles comprising a flexible support insoluble in water and a cosmetic composition carried by the support also called “wipes”, are widely used, especially for make-up removal.
- US Patent 4,303,543 discloses dry wipes that are impregnated with a foaming composition during manufacture and then dried after impregnation.
- Known wipes or sponges comprise a support consisting of a substrate insoluble in water and are a source of solid waste.
- US Patent 6,818,603 discloses a bread soap incorporating fibers, which may be water soluble.
- US Patent 6,576,575 discloses an adhesive bandage comprising water-soluble fibers.
- tablettecloth and “layer” should be considered synonymous.
- the subject of the invention is also a fluid cosmetic or dermatological composition, obtained by the dissolution in water of a support in the form of at least one sheet of a material soluble in water. water and carrying at least one cosmetic or dermatological compound.
- the cosmetic treatment includes makeup.
- the support may especially carry a cosmetic or dermatological composition.
- the cosmetic composition is for example contained in the support or retained thereon.
- solubility in water at a temperature below 20 ° C means solubilization in water at a temperature below 20 ° C with the aid of manual agitation and / or friction the support if necessary, in a period of time typically less than 5 minutes, preferably less than 1 min, preferably less than 30 seconds.
- the invention does not exclude that a water of temperature above 20 ° C is used to dissolve the support.
- a flexible article made in the form of a fibrous web may in some embodiments be folded on itself at least once without breaking into two pieces.
- the article is for example single use.
- the invention as defined above has the advantage of reducing the amount of solid waste produced by the consumer.
- An article made according to the invention can also offer an additional attraction, related to the change of appearance in use, due to the solubilization of the support, which may particularly appeal to young children and encourage them for example to wash more frequently or more sustainably hands or teeth.
- the invention also offers new possibilities for the packaging and formulation of many cosmetic products such as, for example, make-up, hygiene or skin care products, mucous membranes, mouth or hair products.
- the invention may also allow the packaging of powdery cosmetic compositions that do not lend themselves well to conventional packaging methods, such as compaction in a cup or incorporation in a paste, for example.
- the invention can also facilitate the packaging of pasty or powdery cosmetic compositions, difficult to take manually.
- the article may comprise a hair composition, in particular a shampoo, a conditioner or a conditioner for the hair.
- the composition may represent between 10 and 1000% by weight, relative to the weight of the support.
- the support may be in the form of one or more non-fibrous films, obtained for example by evaporation of a solvent, but preferably the support comprises entangled fibers soluble in water, preferably at a temperature below 20 ° C. ° C.
- the support comprises at least one layer of a non-woven material, consisting essentially of fibers soluble in water, preferably at a temperature below 20 ° C., and may comprise at least least one layer of a substrate insoluble in water.
- the support may be substantially non-retractable once wet.
- the support in the case where it comprises a nonwoven, all the appropriate techniques for forming a nonwoven from fibers can be used.
- the fibers can be formed by extrusion and deposited on a conveyor to form a web of fibers which is then consolidated by a conventional technique of bonding fibers such as, for example, needling, heat-bonding, calendering or tying by hot air jets (in English air through bonding), technique in which the sheet passes through a tunnel where is blown hot air.
- a conventional technique of bonding fibers such as, for example, needling, heat-bonding, calendering or tying by hot air jets (in English air through bonding), technique in which the sheet passes through a tunnel where is blown hot air.
- the sheet consists of bicomponent fibers, for example fibers comprising at least two grades of polyvinyl alcohol (PVA), whose melting or softening points are different, these fibers being for example co- extruded so that the fiber consists of at least a first grade located in the core of the fiber and at least a second grade located at the periphery of the fiber, in the form of a sheath.
- PVA polyvinyl alcohol
- the sheet of fibers used for the manufacture of the nonwoven may also be formed by carding fibers cut to a length of 10 to 50 mm, and then depositing the fibers on a conveyor where the sheet may then be consolidated by a binding technique such as as described above.
- the density of the support may depend on the applications.
- the support may have, for example, a density of less than or equal to 0.1 g / cm 3 or not.
- a density less than or equal to 0.1 g / cm 3 better still between 0.01 g / cm 3 and 0.1 g / cm 3 , can make it very airy and facilitate its dissolution in water.
- the support comprises at least two nonwoven layers each consisting essentially of fibers soluble in water, preferably at a temperature below 20 ° C.
- the two layers are for example assembled at their periphery, as illustrated in FIGS. 1 and 2.
- FIG. 1 represents, in plan view, an article 1 comprising two sheets 2 and 3 of a nonwoven formed of water-soluble fibers, assembled by heat-sealing at their periphery so as to constitute a pad capable of holding in an interior cavity 4 a composition C cosmetic or dermatological, as can be seen in Figure 2 (which is a cross section along II-II of Figure 1).
- the support may also comprise only one layer of water-soluble fibers and a cosmetic or dermatological composition may for example be dispersed within this layer or cover one of the faces only.
- FIG. 3 shows schematically in perspective a cosmetic article 6 which comprises a single layer 7 formed of a nonwoven of soluble fibers and in which the composition C is dispersed, this being for example in a pulverulent form as shown in Figure 4 (which is a partial and schematic cross section of Figure 3).
- the article has a rectangular shape but the article could take another form, for example round or oval, having for example dimensions allowing its gripping between two fingers at least.
- the article can form a wipe.
- the support has a generally flattened shape, the maximum thickness e in FIGS. 2 and 4 being, for example, less than 10 mm for an area of between 0.00005 m 2 and 0.01 m. 2 , preferably between 0.0001 m 2 and 0.001 m 2 .
- the support may also have a general non-flattened shape, having for example the appearance of a block, as shown in Figure 5, the latter representing in top view an article 8 formed of a globular cluster of compacted hydrosoluble fibers, incorporating the cosmetic or dermatological composition.
- the article formed by the cosmetic or dermatological composition and the support is intended to be brought into contact with water before use.
- the support is thus first solubilized entirely before the article is applied to the human body.
- it is easy to adjust the apparent viscosity of the composition obtained.
- the article formed by the cosmetic or dermatological composition and the support is intended to be brought into contact with water for its use, but the support is brought into contact with a region of the human body, for example the skin or the hair, before its complete solubilization, even before being wet.
- a region of the human body for example the skin or the hair
- Water can be poured on the item while it is not in contact with the body. The latter may still be wet or water may be projected or poured onto the support while the article is in contact with the region to be treated.
- the article is intended to be used without being impregnated with water.
- the support can be dissolved after use, if the user wishes, for example by being placed in the bottom of a sink and running water on it.
- the article is for example pre-impregnated by the composition or the user can deposit the composition on it.
- the support when the support is not intended to be completely dissolved in water prior to application, the support may have a shape that depends on the region of the body to be treated.
- FIG. 6 an article 9 has been shown, the support 10 of which is of reniform contour, being intended for example for makeup of the eyelids.
- FIG. 7 shows an article 12 whose support 13 forms a mask, with openings or cutouts 14 for the eyes, the nose and the mouth, and in FIG. 8 is shown diagrammatically in FIG. perspective an article 15 whose support 16 forms a charlotte.
- Cosmetic articles comprising a support not entirely soluble in water, especially in water at less than 20 ° C
- Such a support may for example comprise, as illustrated in FIG. 9 (which schematically represents in section an article according to this aspect of the invention), a layer 20 of a water-insoluble substrate covered by a layer 21. composed of water-soluble fibers, the cosmetic composition C being for example retained between the layers 20 and 21, as illustrated.
- the layers 20 and 21 are for example assembled at their periphery by heat sealing or otherwise.
- the substrate 20 is for example a sheet of a synthetic nonwoven, for example a nonwoven of polyethylene fibers, polypropylene, polyethylene terephthalate (PET), polylactic acid, polyamide, viscose, cellulose or a mixture of these fibers ... or a film, which may be permeable or not.
- Nonwovens are generally described in RIEDEL "Nonwoven Bonding Methods & Materials", Nonwoven World (1987), incorporated herein by reference.
- a multilayer structure with at least one layer formed of a water-insoluble substrate may for example be useful for producing an article 22 having a glove-shaped support 23, as illustrated in FIG. 10 (which is a perspective view). schematic), such an article being intended for example for oral hygiene.
- the layer formed of water-soluble fibers is located outside the article, being intended to solubilize during use, after having been wetted or coming into contact with a wet region of the body.
- the insoluble substrate layer 20 may still be in the form of a glove or a muffle.
- the support comprises several layers, whether all these are made with water-soluble or non-water-soluble fibers
- the different layers can be assembled in multiple ways, for example by welding, gluing or sewing, and these layers can constitute, where appropriate, one or several cavities containing one or more cosmetic or dermatological compositions or several components of the same cosmetic composition to be mixed extemporaneously.
- a water-soluble yarn can be used, if necessary.
- the support may comprise, or even consist essentially of, soluble fibers, preferably in water at less than 20 ° C.
- the support may thus comprise, for example, more than 95% by weight, or even more than 99% or more of water-soluble fibers.
- the fibers are made with polyvinyl alcohol (PVA) according to a process which gives them the desired solubility.
- PVA polyvinyl alcohol
- Fibers soluble in water at a temperature below 20 ° C are marketed by the Japanese company KURARAY under the trade name KURALON K-II WN2.
- the process for producing these fibers involves the use of organic solvents.
- the section of these fibers may be substantially circular.
- EP 0 636 716 discloses water-soluble PVA-based fibers and their method of manufacture.
- the invention is not limited to the use of PVA and fibers made in other water-soluble materials can be used provided they dissolve in water having the desired temperature, for example polysaccharide fibers marketed under the LYSORB denomination by the company LYSAC TECHNOLOGIES, INC or fibers based on polysaccharide polymers such as glucomannan or starch.
- the support may comprise, where appropriate, a mixture of fibers soluble in water at different temperatures.
- the fibers may be composite, and include for example a core and a sheath of the same nature, for example formed of different grades of PVA.
- the support may be substantially free of insoluble fibers in the water.
- the support is devoid of adhesive, especially pressure-sensitive adhesive.
- It may be for example compounds intended for makeup, care and / or hygiene and / or cleaning the skin, mouth, mucous membranes or integuments.
- the cosmetic or dermatological composition carried by the support may for example represent between 10 and 1000% by weight, relative to the weight of the support.
- the article may comprise at least one cosmetic or dermatological active ingredient.
- active agents there may be mentioned, for example, without this list being limiting, the antiseborrhoeic active agents which make it possible to clean the excess of sebum on the skin, and the antimicrobial agents which remove from the skin the microorganisms that may be present therein. , and their mixtures.
- antiseborrhoeic active agents examples include sulfur and sulfur derivatives, benzoyl peroxide, zinc derivatives such as zinc sulphate and zinc oxide, aluminum chloride, selenium disulphide, B vitamins and in particular panthenol (vitamin B5) and niacinamide (vitamin B6 or PP), and mixtures thereof.
- antimicrobials examples include: ⁇ -lactam derivatives, quinolone derivatives, ciprofloxacin, norfloxacin, tetracycline and its salts (hydrochloride), erythromycin and its salts (zinc, estolate, stearate), amikacin and its salts (sulphate), 2,4,4'-trichloro-2'-hydroxy diphenyl ether (triclosan), 3,4,4'-trichlorobanilide (tricarban), phenoxyethanol, phenoxypropanol, phenoxyisopropanol, doxycycline and its salts (hydrochloride), careomycin and its salts (sulphate), chlorhexidine and its salts (gluconate, hydrochloride), chlorotetracycline and its salts (hydrochloride), oxytetracycline and its salts (hydrochloride), clindamycin and its salts (hydrochloride), ethambut
- the preferred antimicrobial agents are 2,4,4'-trichloro-2'-hydroxy diphenyl ether, 3,4,4'-trichlorobanilide, phenoxyethanol, phenoxypropanol, phenoxyisopropanol, chlorhexidine and its salts, octopirox , zinc pyrithione, salicylic acid, 5-n-octanoyl salicylic acid, benzoyl peroxide, 3-hydroxybenzoic acid, glycolic acid, lactic acid, 4-hydroxybenzoic acid , acetylsalicylic acid, 2-hydroxybutanoic acid, 2-hydroxypentanoic acid, 2-hydroxyhexanoic acid, phytic acid, N-acetyl-L-cysteine acid, lipoic acid, azelaic acid, arachidonic acid, octoxyglycerine, octanoylglycine, caprylylglycol, 10-hydroxy-2-decanoic acid, and
- composition may comprise active agents acting on the barrier function of the skin, active agents that promote the hydration of the skin and desquamating agents.
- vitamins C, A, E, F, B, or PP
- essential fatty acids essential oils
- sunscreens especially liposoluble or in the form of nanoparticles. particles
- specific skin treatment active ingredients anti-odor, anti-wrinkle, etc.
- self-tanning agents all plant extracts, mineral or marine extracts, antiradical or soothing substances, slimming substances (caffeine, etc.) .
- All these active ingredients can be used, for example, at concentrations of 0 to 20% and in particular from 0.001 to 15%, relative to the total weight of the composition.
- All or part of the assets may be encapsulated, if any.
- the article may comprise at least one coloring agent, in an amount of between 0 and 100%, for example between 0 to 95%, preferably between 0.1 to 50%, and better still from 1 to 25% of the total weight of the composition, especially at least one pigment or dye, for example a coloring agent chosen from inorganic pigments, organic pigments or lakes, pearlescent pigments, composite pigments, fat-soluble and water-soluble dyes.
- at least one coloring agent in an amount of between 0 and 100%, for example between 0 to 95%, preferably between 0.1 to 50%, and better still from 1 to 25% of the total weight of the composition, especially at least one pigment or dye, for example a coloring agent chosen from inorganic pigments, organic pigments or lakes, pearlescent pigments, composite pigments, fat-soluble and water-soluble dyes.
- the mineral pigments can be coated or not. Titanium dioxide, optionally surface-treated, oxides of zirconium or cerium, as well as iron or chromium oxides, manganese violet, ultramarine blue, chromium hydrate and ferric blue may be mentioned.
- the pearlescent pigments may be chosen from white pearlescent pigments such as mica coated with titanium or bismuth oxychloride, colored pearlescent pigments such as titanium mica with iron oxides, titanium mica with in particular ferric blue or with chromium oxide, gold-colored mother-of-pearls as sold by the company Engelhard under the name Brilliant gold 212G (Timica), Gold 222C (Cloisonne), Sparkle gold (Timica), Gold 4504 (Chromalite) and Monarch gold 233X (Cloisonne); bronze nacres sold especially by the company Merck under the name Bronze Fine (17384) (Colorona) and Bronze (17353) (Colorona) and by Engelhard under the name Super Bronze (Cloisonne); orange nacres sold especially by the company Engelhard under the name Orange 363C (Cloisonne) and Orange MCR 101 (Cosmica) and by the company Merck under the name Passion Orange (Colorona) and Matte Orange (17449) (Microna); brown-colored pearlescent agents marketed by
- the water-soluble dyes are chosen for example from plant extracts, in particular beet juice and methylene blue.
- the coloring agent may comprise at least one organic dyestuff, for example at least one organic pigment and / or at least one organic lacquer.
- organic pigments mention may be made of those known under the following names: D & C Blue No. 4, D & C Brown No. 1, D & C Green No. 5, D & C Green No. 6, D & C Orange No. 4, D & C Orange No. 5, D & C Orange No. 10, D & C Orange No. 11, D & C Red No. 6, D & C Red No. 7, D & C Red No. 17, D & C Red No. 21, D & C Red No. 22, D & C Red No. 27, D & C Red No. 28, D & C Red No. 30, D & C Red No. 31, D & C Red No. 33, D & C Red No. 34, D & C Red No. 36, D & C Violet No.
- the organic dyestuff may comprise an organic lacquer supported by an organic support such as rosin or aluminum benzoate, for example.
- the article may comprise at least one goniochromatic coloring agent.
- the goniochromatic coloring agent may be chosen for example from interferential multilayer structures and liquid crystal coloring agents, for example Fe 2 O 3 / SiO 2 / Fe 2 O 3 / SiO 2 / Fe 2 O 3 , a pigment having this structure being marketed under the name SICOPEARL by BASF, MoS 2 / SiO 2 / mica-oxide / SiO 2 / MoS 2 , Fe 2 O 3 / SiO 2 / mica-oxide / SiO 2 / Fe 2 O 3 , TiO 2 / SiO 2 / TiO 2 or TiO 2 / Al 2 O 3 / TiO 2 , pigments having these structures being sold under the name XIRONA by the company Merck (Darmstadt).
- the coloring agent may also comprise a diffractive pigment having, for example, the MgF 2 / Al / MgF 2 structure , as sold under the name SPECTRAFLAIR 1400 Pigment Silver by the company FLEX PRODUCTS, or SPECTRAFLAIR 1400 Pigment Silver FG.
- SPECTRAFLAIR 1400 Pigment Silver by the company FLEX PRODUCTS, or SPECTRAFLAIR 1400 Pigment Silver FG.
- the article may comprise, in addition to the particulate phase comprising the pigments, at least one binder comprising at least one elastomeric solid hydrophilic organopolysiloxane.
- binder comprising at least one elastomeric solid hydrophilic organopolysiloxane.
- the article may comprise one or more film-forming agents, for example when it is intended for make-up or for forming a peelable film or a care mask.
- the support itself can serve as a film-forming agent after dissolution, especially when the support is made of PVA.
- the support can thus be in an amount sufficient to allow the formation of a continuous film on keratin materials.
- the article may comprise other film-forming agents, which may be chosen as a function, for example, of the nature of the support.
- film-forming agents may be chosen from synthetic polymers, of radical type or of polycondensate type, polymers of natural origin, and their mixtures.
- the radical-type film-forming polymers may be, for example, vinyl polymers or copolymers, in particular acrylic polymers.
- the vinyl film-forming polymers may result from the polymerization of ethylenically unsaturated monomers having at least one acid group and / or esters of these acid monomers and / or amides of these acidic monomers such as ⁇ , ⁇ -ethylenic unsaturated carboxylic acids.
- film-forming polycondensates there may be mentioned polyurethanes, polyesters, polyesters amides, polyamides, and polyureas, this list not being limiting.
- the polymers of natural origin may be selected from shellac resin, sandarac gum, dammars, elemis, copal, cellulosic polymers.
- the article may also contain any ingredients commonly used in cosmetics or dermatology and physiologically acceptable, such as for example fillers, thickeners, surfactants, trace elements, sequestering agents, perfumes, alkalizing or acidifying agents, preservatives and antioxidants.
- ingredients commonly used in cosmetics or dermatology and physiologically acceptable such as for example fillers, thickeners, surfactants, trace elements, sequestering agents, perfumes, alkalizing or acidifying agents, preservatives and antioxidants.
- the article may also include a mixture of these surfactants.
- the article may comprise compounds intended to react together in the presence of water, for example to cause effervescence, for example at least one organic acid, in particular citric acid, and at least one alkaline agent, for example sodium bicarbonate. welded.
- At least one cosmetic or dermatological compound and more generally the cosmetic or dermatological composition may or may not be present outside the article.
- the composition When the composition is present outside the article, the latter can be used for example by being brought into contact with the region to be treated, so as to allow the composition to transfer. This transfer can be made, if necessary, by rubbing the article on the region to be treated.
- composition in the case where the composition is present on the outside of the article, the latter may not be wet during use, the solubilization of the support taking place after use.
- the article may nevertheless in certain cases be wet during use, for example to modify properties of the composition, improve the transfer of the composition or form a film-forming product.
- the support may have to be solubilized at least partially or completely before use.
- the composition may be present in the article at least partially, or totally, in a pulverulent form, in particular a substantially anhydrous pulverulent form.
- the article may, for example, be dry to the touch.
- the particle size of the composition may be chosen according to the porosity of the support so as to reduce the shaking losses.
- composition when it is pulverulent, may be contained in a cavity of the support, for example formed between two layers thereof, as is the case of the embodiment of FIG. 2, or dispersed by homogeneously example, within the support, in particular within a single fibrous layer of the support as is the case of the embodiment of Figure 4.
- the composition may not be pulverulent but may be liquid, creamy or pasty, forming for example a paste.
- the composition comprises, for example, one or more solvents compatible with the nature of the support, in particular non-aqueous solvents, so as to avoid premature dissolution, such as, for example, lower alcohols containing from 1 to 6 carbon atoms, such as ethanol; polyols such as glycerine; glycols such as butylene glycol, isoprene glycol, hexylene glycol, propylene glycol; polyethylene glycols such as PEG-8, sorbitol; hydrocarbon oils of animal origin, such as perhydrosqualene; hydrocarbon oils of vegetable origin, such as glycerides mono- or di- or tri-esters of fatty acids and of glycerol, for example sweet almond, sunflower, corn, soybean or hazelnut oils, apricot; triglycerides of synthetic origin, such as those sold by Stearineries Dubois or those
- fluorinated oils mention may also be made of perfluoromethylcyclopentane and perfluoro-1,3-dimethylcyclohexane, sold under the names "FLUTEC PC1®” and “FLUTEC PC3®” by BNFL Fluorochemicals; perfluoroalkanes such as dodecafluoropentane and tetradecafluorohexane sold under the names "PF 5050®” and "PF 5060®” by the company 3M; silicone oils such as volatile or non-volatile polymethylsiloxanes (PDMS) with a linear or cyclic silicone chain, which are liquid or pasty at room temperature, in particular cyclopolydimethylsiloxanes (cyclomethicones) such as cyclohexasiloxane; polydimethylsiloxanes comprising alkyl, alkoxy or phenyl groups, during or at the end of the silicone chain, groups having from 2 to 24 carbon atoms; phen
- hydrocarbon-based oil in the list of oils mentioned above, any oil predominantly comprising carbon and hydrogen atoms, and optionally ester, ether, fluoro, carboxylic acid and / or alcohol groups.
- the composition may contain a certain amount of water at the time of its impregnation on the support.
- the water introduced on the support during its impregnation will be eliminated by the means conventionally used for the dehydration of compositions containing water, such as heating.
- composition can be deposited on one side only of the support, the other side of the support can be used for example for gripping the article.
- the article is packaged for example in a package such as a box 30, as illustrated in FIG. 11.
- a control 31 indicative of the color of the product obtained after dissolution of the support may appear on the packaging, if any, to inform the consumer before the purchase.
- the article When the composition is incorporated during the manufacture of the article therein, the article is for example packaged in bulk in a box or in an individual package. In this case, the articles are packed in a rosary. The articles can still be folded on themselves and interposed, so that the removal of an article brings the next in a configuration facilitating its grip.
- the composition and the support may be provided in the form of a kit, for example.
- the composition is for example delivered in an amount sufficient to allow to distribute a plurality of doses on a set of media to be used successively.
- EXAMPLE A Makeup of the Skin, in particular the Eyelids A support is made by cutting an ovoid shape approximately 5 cm long and 1.5 cm wide from a KURALON K-II WN2 sheet approximately of thickness 0.5mm and weight 60 g / m 2 .
- this support is impregnated with an amount of between 0.02 g and 0.1 g of the following colored pulverulent composition deposited on one side thereof.
- Mica 14% Ferric Ferrocyanide 6% Talc 8% Calcium Sodium Borosilicate 60% Titanium dioxide 10% Ethylhexyl palmitate 1.5% conservatives 0,5%
- the support thus impregnated is soft to the touch and easy to grip especially by its opposite side to that bearing the composition and can be moved on the skin so as to allow the composition to transfer on it.
- the impregnation of the support can be carried out at the time of use or the support can be offered to the pre-impregnated user, in particular individual packaging.
- Example B Makeup of the skin, especially cheeks
- a support is made by cutting a round shape about 5 cm in diameter in a sheet of KURALON K-II WN2 thickness of about 2mm and 80 g / m 2 basis weight.
- This support is impregnated with 0.1 g of the following powdery composition deposited on one side thereof.
- Mica 30 % Pigments of iron oxides and zinc oxides 3.5% Talc 35% Titanium dioxide 5% Nylon 12 20% Ethylhexyl palmitate 2% Mineral oil 4% conservatives 0,5%
- Example C Make-up of the skin, in particular of the face
- Example A The same support as in Example A is coated with 0.25 g of the following anhydrous pasty blush composition: Mica 2% Pigments based on iron oxides 3% Talc 4% Nylon 12 2% Hydrogenated styrene isoprene copolymer 10% isohexadecane 25% Disteardimonium hectorite 2% Silica 5% Isononyl isononanoate 15% Polymethyl methacrylate 15% Distillates of Petroleum 17%
- the support is easily removed by dissolution in cold water.
- Example D Makeup of the skin
- FIGS. 1 and 2 An article such as that illustrated in FIGS. 1 and 2 is made with KURALON K-II WN2 fibers by thermosealing the layers 2 and 3 at their periphery, and having previously introduced the cosmetic composition into the cavity 4.
- the layers 2 and 3 have a grammage of between 70 and 80 g / m 2 and a thickness of between 3 and 4 mm.
- the article is in the form of a disk 3 cm in diameter containing about 0.3 g of a powdery colored composition having the following formulation: Titanium oxide (untreated anatase) 20% Yellow iron oxide 4.5% Yellow brown iron oxide 4% Black iron oxide 1% Nylon powder (Orgasol from Atochem) 30 % Dimethicone / vinyl dimethicone crosspolymer 35.5% glycerol 4.5% preservatives 0,5%
- the article To use the article, it is placed in the palm of the hand and water is poured on the support.
- the PVA fibers contribute to texture the composition and / or give it film-forming properties.
- the user can act on the texture of the product by adding more or less water.
- the product thus formed can be spread on the body or face directly with the fingers or by using an applicator, for example a flocked tip, such as a foam, a felt, cotton or a brush.
- an applicator for example a flocked tip, such as a foam, a felt, cotton or a brush.
- An article comprising a support constituted by a disc 7 cm in diameter of a sheet of KURALON K-II WN2 fibers of grammage 80 g / m 2 and 2 mm thick, impregnated with 0.2 g of a powdery deodorant composition having the following formulation: Cetylstearyl alcohol 2% Perfume 0.5% conservatives 0,5% Poly dimethyl siloxane 0,5% Hydroxy aluminum chloride 96.5%
- the item is used dry, wiping underarms.
- the affinity for the water of the support makes it possible to wipe off any residues of perspiration.
- Example F Skin cleansing
- FIGS. 1 and 2 An article such as that illustrated in FIGS. 1 and 2 is made with KURALON K-II WN2 fibers by thermosealing the layers 2 and 3 at their periphery, and having previously introduced the cosmetic composition into the cavity 4.
- the article is presented in the form of a disk 3 cm in diameter
- the article contains about 0.3 g of a powdery cleaning composition having the following formulation: Starch (octenyl succinyl starch) 40% Sodium cocoyl isethionate 34.9% Potassium laurate 10% Potassium myristate 10% Perfume 3% Salicylic acid 2% conservatives 0.1%
- the article To use the article, it is placed in the palm of the hand and poured about 3cm 3 of water on it.
- This foam can be used to wash your hands or face, for example.
- Example G Skin cleansing
- a wipe is made in the following manner.
- a sheet of 10 cm by 60 g / m 2 and 1 mm thick is cut into KURALON K-II WN2 which is impregnated with 0.9 g of the following concentrated foaming composition: Sodium laureth sulfate 70% in water 50% (Texapon N702 from Cognis) Disodium cocoamphodiacetate at 39% in brine (11% sodium chloride) Miranol C2M from Rhodia 24.9% Lauroyl sodium sarcosinate 90% in water (Sarkosyl NL97 from Ciba Geigy) 16.9% Perfume 3% Glycerol 5% conservatives 0.3%
- This composition contains at least 15% water. It is in the form of a paste that is deposited on the support by conventional means, such as coating for example.
- composition is dried, and the composition adheres to the fibers once dry.
- the support is calendered between rollers, to densify, stiffen and reduce surface porosity.
- the wipe is passed under water and then rubbed to create the foam and solubilize the support.
- Example H Shaving of the skin
- An article for shaving is produced with the same support as that of ExampleE, the composition of the preceding example being replaced by the following: Stearic acid 10% Palmitic acid 10% Myristic acid 10% Dimethiconol stearate 0,5% Disodium cocoamphodiacetate 5% Potassium hydroxide 8% Water 51.2% Glycerol 5% conservatives 0.3%
- This composition contains at least 15% water. It is in the form of a paste that is deposited on the support by conventional means such as coating for example.
- composition is dried, and the composition adheres to the fibers once dry.
- the support is calendered between rollers, to densify, stiffen and reduce surface porosity.
- a makeup remover is made for makeup removing the face with the same support as that of Example E, the composition of the previous example being replaced by the following: Parleam Oil 40% isohexadecane 28% Dextrin palmitate (Rheopearl TL) 2% PEG-20 glyceryl tri-isostearate 25% Simulgel 600 (CTFA name: Acrylamide / Sodium acryloyldimethyltaurate copolymer / Isohexadecane / Polysorbate 80) 5%
- composition is anhydrous, it is impregnated on the support by conventional means such as for example lick rollers or impregnation ramps.
- a cleansing emulsion is generated by passing the leaf on the wet face or better by rubbing it in the palm of the hand with a little water.
Abstract
Description
La présente invention concerne, notamment, les articles cosmétiques ou dermatologiques comportant au moins un support et au moins une composition cosmétique portée par le support.The present invention relates, in particular, to cosmetic or dermatological articles comprising at least one support and at least one cosmetic composition carried by the support.
Des articles comportant un support souple insoluble dans l'eau et une composition cosmétique portée par le support, encore appelés « lingettes », sont très largement utilisés, pour le démaquillage notamment.Articles comprising a flexible support insoluble in water and a cosmetic composition carried by the support, also called "wipes", are widely used, especially for make-up removal.
Des lingettes humides imprégnées d'une composition aqueuse moussante sont ainsi connues par les publications WO 02/092050, WO 02/092052 et US 6 287 757, entre autres.Wet wipes impregnated with an aqueous foaming composition are thus known from publications WO 02/092050, WO 02/092052 and US 6,287,757, among others.
Le brevet US 4 303 543 divulgue des lingettes sèches qui sont imprégnées d'une composition moussante durant la fabrication puis séchées après imprégnation.US Patent 4,303,543 discloses dry wipes that are impregnated with a foaming composition during manufacture and then dried after impregnation.
La publication WO 00/07561 décrit des éponges bicouche renfermant une dose de poudre moussante.Publication WO 00/07561 describes bilayer sponges containing a dose of foaming powder.
Les lingettes ou éponges connues comportent un support constitué d'un substrat insoluble dans l'eau et sont une source de déchets solides.Known wipes or sponges comprise a support consisting of a substrate insoluble in water and are a source of solid waste.
Le brevet US 6 818 603 divulgue un savon en pain incorporant des fibres, lesquelles peuvent être hydrosolubles.US Patent 6,818,603 discloses a bread soap incorporating fibers, which may be water soluble.
Le brevet US 6 576 575 décrit un pansement adhésif comportant des fibres solubles dans l'eau.US Patent 6,576,575 discloses an adhesive bandage comprising water-soluble fibers.
L'invention réside, selon l'un de ses aspects, dans un article cosmétique ou dermatologique comportant :
- un support sous forme d'au moins une nappe d'un matériau soluble dans l'eau à une température inférieure à 20 °C, et
- au moins un composé cosmétique ou dermatologique porté par le support.
- a carrier in the form of at least one web of water-soluble material at a temperature below 20 ° C, and
- at least one cosmetic or dermatological compound carried by the support.
Les termes « nappe » et « couche » doivent être considérés comme synonymes.The terms "tablecloth" and "layer" should be considered synonymous.
L'invention a encore pour objet, selon un autre de ses aspects, une composition cosmétique ou dermatologique fluide, obtenue par la dissolution dans l'eau d'un support sous forme d'au moins une nappe d'un matériau soluble dans l'eau et portant au moins un composé cosmétique ou dermatologique.According to another of its aspects, the subject of the invention is also a fluid cosmetic or dermatological composition, obtained by the dissolution in water of a support in the form of at least one sheet of a material soluble in water. water and carrying at least one cosmetic or dermatological compound.
Par « fluide », il faut comprendre « qui peut s'écouler sous l'effet de son propre poids ».By "fluid" it is necessary to understand "which can flow under the effect of its own weight".
L'invention a encore pour objet, selon un autre de ses aspects, un procédé de traitement cosmétique ou dermatologique, comportant :
- la formation d'une composition cosmétique ou dermatologique par dissolution dans l'eau d'un support comportant :
- un matériau soluble dans l'eau, notamment une nappe d'un tel matériau, et
- au moins un composé cosmétique ou dermatologique porté par le support,
- l'application de la composition ainsi formée sur le corps humain, par exemple sur des matières kératiniques.
- forming a cosmetic or dermatological composition by dissolving in water a carrier comprising:
- a material soluble in water, in particular a sheet of such material, and
- at least one cosmetic or dermatological compound carried by the support,
- the application of the composition thus formed on the human body, for example on keratin materials.
Le traitement cosmétique comprend le maquillage.The cosmetic treatment includes makeup.
L'invention a encore pour objet, selon un autre de ses aspects, un article cosmétique comportant :
- au moins une composition cosmétique,
- au moins une nappe de fibres hydrosolubles dans l'eau, de préférence à une température inférieure à 20 °C, la densité de la nappe étant inférieure ou égale à 0,1 g/cm3.
- at least one cosmetic composition,
- at least one layer of water-soluble fibers in water, preferably at a temperature below 20 ° C, the density of the web being less than or equal to 0.1 g / cm3.
L'invention a encore pour objet un article cosmétique comportant :
- au moins deux couches définissant entre elles une cavité, l'une au moins des couches étant soluble dans l'eau,
- au moins une composition cosmétique dans la cavité.
- at least two layers defining between them a cavity, at least one of the layers being soluble in water,
- at least one cosmetic composition in the cavity.
L'invention a encore pour objet, selon un autre de ses aspects, un ensemble comportant :
- un emballage,
- au moins un article tel que défini plus haut. Cet emballage peut comporter un témoin coloré représentatif de la couleur de la composition.
- a packaging,
- at least one article as defined above. This package may comprise a colored indicator representative of the color of the composition.
L'invention réside, selon un autre de ses aspects, dans un article cosmétique ou dermatologique, non adhésif, de préférence souple, comportant :
- au moins un support soluble dans l'eau, de préférence entièrement soluble dans l'eau, de préférence encore à une température inférieure à 20 °C,
- au moins un composé cosmétique ou dermatologique porté par le support.
- at least one water-soluble carrier, preferably fully soluble in water, more preferably at a temperature below 20 ° C,
- at least one cosmetic or dermatological compound carried by the support.
Le support peut notamment porter une composition cosmétique ou dermatologique.The support may especially carry a cosmetic or dermatological composition.
La composition cosmétique est par exemple contenue dans le support ou retenue sur celui-ci.The cosmetic composition is for example contained in the support or retained thereon.
Par « soluble dans l'eau à une température inférieure à 20 °C », il faut comprendre une solubilisation dans l'eau à une température inférieure à 20 °C avec l'aide d'une agitation manuelle et/ou d'une friction du support le cas échéant, dans un laps de temps typiquement inférieur à 5 mn, de préférence inférieur à 1 mn, de préférence inférieur à 30 secondes. L'invention n'exclut pas qu'une eau de température supérieure à 20 °C soit utilisée pour dissoudre le support."Soluble in water at a temperature below 20 ° C" means solubilization in water at a temperature below 20 ° C with the aid of manual agitation and / or friction the support if necessary, in a period of time typically less than 5 minutes, preferably less than 1 min, preferably less than 30 seconds. The invention does not exclude that a water of temperature above 20 ° C is used to dissolve the support.
Par « souple », il faut comprendre un article pouvant être comprimé ou fléchir sans se rompre, capable de s'adapter aux reliefs du corps humain. Un article souple réalisé sous la forme d'une nappe fibreuse peut dans certains exemples de réalisation être replié sur lui-même au moins une fois sans se casser en deux morceaux.By "flexible", we must understand an article that can be compressed or flex without breaking, able to adapt to the reliefs of the human body. A flexible article made in the form of a fibrous web may in some embodiments be folded on itself at least once without breaking into two pieces.
L'article est par exemple à usage unique.The article is for example single use.
L'invention telle que définie ci-dessus présente l'avantage de réduire la quantité de déchets solides produits par le consommateur.The invention as defined above has the advantage of reducing the amount of solid waste produced by the consumer.
Un article réalisé conformément à l'invention peut offrir également un attrait supplémentaire, lié au changement d'aspect à l'utilisation, dû à la solubilisation du support, ce qui peut plaire notamment aux jeunes enfants et les inciter par exemple à se laver plus fréquemment ou de façon plus soutenue les mains ou les dents.An article made according to the invention can also offer an additional attraction, related to the change of appearance in use, due to the solubilization of the support, which may particularly appeal to young children and encourage them for example to wash more frequently or more sustainably hands or teeth.
L'invention offre encore de nouvelles possibilités pour le conditionnement et la formulation de nombreux produits cosmétiques tels que par exemple les produits de maquillage, d'hygiène ou de soin de la peau, des muqueuses, de la bouche ou des cheveux.The invention also offers new possibilities for the packaging and formulation of many cosmetic products such as, for example, make-up, hygiene or skin care products, mucous membranes, mouth or hair products.
L'invention peut également permettre le conditionnement de compositions cosmétiques pulvérulentes se prêtant mal aux modes de conditionnement conventionnels, tels que le compactage dans une coupelle ou l'incorporation dans une pâte, par exemple.The invention may also allow the packaging of powdery cosmetic compositions that do not lend themselves well to conventional packaging methods, such as compaction in a cup or incorporation in a paste, for example.
L'invention peut aussi faciliter le conditionnement de compositions cosmétiques pâteuses ou pulvérulentes, difficiles à prélever manuellement.The invention can also facilitate the packaging of pasty or powdery cosmetic compositions, difficult to take manually.
L'article peut comporter une composition capillaire, notamment un shampoing, un après-shampoing ou un soin conditionneur des cheveux.The article may comprise a hair composition, in particular a shampoo, a conditioner or a conditioner for the hair.
La composition peut représenter entre 10 et 1000 % en poids, par rapport au poids du support.The composition may represent between 10 and 1000% by weight, relative to the weight of the support.
Le support peut se présenter sous la forme d'un ou plusieurs films non fibreux, obtenus par exemple par évaporation d'un solvant, mais de préférence le support comporte des fibres enchevêtrées solubles dans l'eau, de préférence à une température inférieure à 20 °C.The support may be in the form of one or more non-fibrous films, obtained for example by evaporation of a solvent, but preferably the support comprises entangled fibers soluble in water, preferably at a temperature below 20 ° C. ° C.
Dans un exemple de mise en oeuvre de l'invention, le support comporte au moins une couche d'un non tissé, constituée essentiellement de fibres solubles dans l'eau, de préférence à une température inférieure à 20 °C, et peut comporter au moins une couche d'un substrat insoluble dans l'eau.In an exemplary embodiment of the invention, the support comprises at least one layer of a non-woven material, consisting essentially of fibers soluble in water, preferably at a temperature below 20 ° C., and may comprise at least least one layer of a substrate insoluble in water.
Le support peut être sensiblement non rétractable une fois mouillé.The support may be substantially non-retractable once wet.
Pour fabriquer le support dans le cas où celui-ci comporte un non-tissé, toutes les techniques appropriées de constitution d'un non-tissé à partir de fibres peuvent être utilisées.To manufacture the support in the case where it comprises a nonwoven, all the appropriate techniques for forming a nonwoven from fibers can be used.
Par exemple, les fibres peuvent être formées par extrusion et déposées sur un convoyeur pour former une nappe de fibres qui est ensuite consolidée par une technique classique de liage de fibres telle que par exemple l'aiguilletage, le liage à chaud, le calandrage ou le liage par jets d'air chaud (en anglais air through bonding), technique dans laquelle la nappe passe dans un tunnel où est insufflé de l'air chaud. Cette dernière technique est avantageusement utilisée lorsque la nappe est constituée de fibres bicomposant, par exemple des fibres comprenant au moins deux grades d'alcool polyvinylique (PVA), dont les points de fusion ou de ramollissement sont différents, ces fibres étant par exemple co-extrudées de manière à ce que la fibre soit constituée d'au moins un premier grade localisé au coeur de la fibre et d'au moins un deuxième grade localisé en périphérie de la fibre, sous la forme d'une gaine. Cela peut faciliter le liage des fibres lorsque la gaine présente un point de fusion plus faible que le coeur.For example, the fibers can be formed by extrusion and deposited on a conveyor to form a web of fibers which is then consolidated by a conventional technique of bonding fibers such as, for example, needling, heat-bonding, calendering or tying by hot air jets (in English air through bonding), technique in which the sheet passes through a tunnel where is blown hot air. The latter technique is advantageously used when the sheet consists of bicomponent fibers, for example fibers comprising at least two grades of polyvinyl alcohol (PVA), whose melting or softening points are different, these fibers being for example co- extruded so that the fiber consists of at least a first grade located in the core of the fiber and at least a second grade located at the periphery of the fiber, in the form of a sheath. This can facilitate fiber binding when the sheath has a lower melting point than the core.
La nappe de fibres servant à la fabrication du non-tissé peut encore être formée par cardage de fibres découpées à une longueur de 10 à 50 mm, puis dépôt des fibres sur un convoyeur où la nappe peut ensuite être consolidée par une technique de liage telle que décrite ci-dessus.The sheet of fibers used for the manufacture of the nonwoven may also be formed by carding fibers cut to a length of 10 to 50 mm, and then depositing the fibers on a conveyor where the sheet may then be consolidated by a binding technique such as as described above.
La densité du support pourra dépendre des applications. Le support peut présenter, par exemple, une densité inférieure ou égale à 0,1 g/cm3 ou non. Une densité inférieure ou égale à 0,1 g/cm3, mieux entre 0,01 g/cm3 et 0,1 g/cm3, peut le rendre très aéré et faciliter sa dissolution dans l'eau.The density of the support may depend on the applications. The support may have, for example, a density of less than or equal to 0.1 g / cm 3 or not. A density less than or equal to 0.1 g / cm 3 , better still between 0.01 g / cm 3 and 0.1 g / cm 3 , can make it very airy and facilitate its dissolution in water.
Dans un exemple de réalisation, le support comporte au moins deux couches de non tissé constituées chacune essentiellement de fibres solubles dans l'eau, de préférence à une température inférieure à 20 °C.In an exemplary embodiment, the support comprises at least two nonwoven layers each consisting essentially of fibers soluble in water, preferably at a temperature below 20 ° C.
Les deux couches sont par exemple assemblées à leur périphérie, comme illustré sur les figures 1 et 2.The two layers are for example assembled at their periphery, as illustrated in FIGS. 1 and 2.
La figure 1 représente, en vue de dessus, un article 1 comportant deux feuilles 2 et 3 d'un non tissé formé de fibres hydrosolubles, assemblées par thermosoudage à leur périphérie de manière à constituer un coussinet capable de retenir dans une cavité intérieure 4 une composition C cosmétique ou dermatologique, comme on peut le voir sur la figure 2 (laquelle est une coupe transversale selon II-II de la figure 1).FIG. 1 represents, in plan view, an
Le support peut encore ne comporter qu'une seule couche de fibres hydrosolubles et une composition cosmétique ou dermatologique peut par exemple être dispersée au sein de cette couche ou en recouvrir l'une des faces seulement.The support may also comprise only one layer of water-soluble fibers and a cosmetic or dermatological composition may for example be dispersed within this layer or cover one of the faces only.
On a représenté de manière schématique en perspective à la figure 3 un article cosmétique 6 qui comporte une couche unique 7 formée d'un non tissé de fibres solubles et dans laquelle la composition C est dispersée, celle-ci étant par exemple sous une forme pulvérulente, comme illustré à la figure 4 (laquelle est une coupe transversale partielle et schématique de la figure 3).FIG. 3 shows schematically in perspective a
Sur la figure 3, l'article présente une forme rectangulaire mais l'article pourrait prendre une autre forme, par exemple ronde ou ovale, ayant par exemple des dimensions permettant sa préhension entre deux doigts au moins. L'article peut former une lingette.In Figure 3, the article has a rectangular shape but the article could take another form, for example round or oval, having for example dimensions allowing its gripping between two fingers at least. The article can form a wipe.
Dans les exemples des figures 1 et 3, le support présente une forme générale aplatie, l'épaisseur maximale e sur les figures 2 et 4 étant par exemple inférieure à 10 mm pour une surface comprise entre 0,00005 m2 et 0,01 m2, de préférence comprise entre 0,0001 m2 et 0,001m2.In the examples of FIGS. 1 and 3, the support has a generally flattened shape, the maximum thickness e in FIGS. 2 and 4 being, for example, less than 10 mm for an area of between 0.00005 m 2 and 0.01 m. 2 , preferably between 0.0001 m 2 and 0.001 m 2 .
Le support peut encore présenter une forme générale non aplatie, présentant par exemple l'aspect d'un bloc, comme illustré à la figure 5, cette dernière représentant en vue de dessus un article 8 formé d'un amas globulaire de fibres hydrosolubles compactées, incorporant la composition cosmétique ou dermatologique.The support may also have a general non-flattened shape, having for example the appearance of a block, as shown in Figure 5, the latter representing in top view an article 8 formed of a globular cluster of compacted hydrosoluble fibers, incorporating the cosmetic or dermatological composition.
Dans un exemple de mise en oeuvre de l'invention, l'article formé par la composition cosmétique ou dermatologique et le support est destiné à être mis en contact avec l'eau avant son utilisation. Le support est ainsi d'abord solubilisé entièrement avant que l'article ne soit appliqué sur le corps humain. Selon la quantité d'eau rajoutée à l'article pour solubiliser le support, on peut aisément ajuster la viscosité apparente de la composition obtenue.In an exemplary implementation of the invention, the article formed by the cosmetic or dermatological composition and the support is intended to be brought into contact with water before use. The support is thus first solubilized entirely before the article is applied to the human body. Depending on the amount of water added to the article to solubilize the support, it is easy to adjust the apparent viscosity of the composition obtained.
Dans une variante de mise en oeuvre de l'invention, l'article formé par la composition cosmétique ou dermatologique et le support est destiné à être mis en contact avec de l'eau pour son utilisation, mais le support est mis au contact d'une région du corps humain, par exemple la peau ou les cheveux, avant sa solubilisation complète, voire avant d'être mouillé. Cela peut permettre par exemple, selon la quantité d'eau ajoutée, de modifier les propriétés en fonction du résultat souhaité. L'eau peut être versée sur l'article alors que celui-ci n'est pas au contact du corps. Ce dernier peut encore être mouillé ou de l'eau être projetée ou versée sur le support alors que l'article est au contact de la région à traiter.In an alternative embodiment of the invention, the article formed by the cosmetic or dermatological composition and the support is intended to be brought into contact with water for its use, but the support is brought into contact with a region of the human body, for example the skin or the hair, before its complete solubilization, even before being wet. This may allow, for example, depending on the amount of water added, to modify the properties according to the desired result. Water can be poured on the item while it is not in contact with the body. The latter may still be wet or water may be projected or poured onto the support while the article is in contact with the region to be treated.
Dans un autre exemple encore de mise en oeuvre de l'invention, l'article est prévu pour être utilisé sans être imprégné par de l'eau. Dans ce cas, le support peut n'être dissout qu'après l'utilisation, si l'utilisateur le souhaite, en étant par exemple déposé au fond d'un lavabo et en faisant couler de l'eau dessus. L'article est par exemple préimprégné par la composition ou l'utilisateur peut déposer la composition dessus.In yet another example of implementation of the invention, the article is intended to be used without being impregnated with water. In this case, the support can be dissolved after use, if the user wishes, for example by being placed in the bottom of a sink and running water on it. The article is for example pre-impregnated by the composition or the user can deposit the composition on it.
Notamment lorsque le support n'est pas destiné à être dissout entièrement dans l'eau préalablement à l'application, le support peut présenter une forme qui dépend de la région du corps à traiter.In particular, when the support is not intended to be completely dissolved in water prior to application, the support may have a shape that depends on the region of the body to be treated.
On a ainsi représenté, en vue de dessus à la figure 6, un article 9 dont le support 10 est de contour réniforme, étant destiné par exemple au maquillage des paupières.In FIG. 6, an
On a représenté en vue de face à la figure 7 un article 12 dont le support 13 forme un masque, avec des ouvertures ou découpes 14 pour les yeux, le nez et la bouche, et sur la figure 8 on a représenté de manière schématique en perspective un article 15 dont le support 16 forme une charlotte.FIG. 7 shows an
L'invention réside encore, selon un autre de ses aspects, dans un article cosmétique ou dermatologique, de préférence souple, comportant :
- au moins un support présentant une structure multicouche avec
- au moins une couche entièrement soluble dans l'eau, notamment à une température inférieure à 20 °C,
- au moins une couche d'un substrat insoluble dans l'eau, notamment à une température inférieure à 20 °C,
- au moins une composition cosmétique portée par le support.
- at least one support having a multilayer structure with
- at least one layer fully soluble in water, especially at a temperature below 20 ° C,
- at least one layer of a substrate insoluble in water, especially at a temperature below 20 ° C,
- at least one cosmetic composition carried by the support.
Un tel support peut par exemple comporter, comme illustré à la figure 9 (qui représente de manière schématique en coupe un article selon cet aspect de l'invention), une couche 20 d'un substrat insoluble dans l'eau recouverte par une couche 21 constituée de fibres hydrosolubles, la composition cosmétique C étant par exemple retenue entre les couches 20 et 21, comme illustré. Les couches 20 et 21 sont par exemple assemblées à leur périphérie par thermosoudage ou autrement.Such a support may for example comprise, as illustrated in FIG. 9 (which schematically represents in section an article according to this aspect of the invention), a
Le substrat 20 est par exemple une feuille d'un non-tissé synthétique, par exemple un non-tissé de fibres de polyéthylène, de polypropylène, de polyéthylène téréphtalate (PET), d'acide polylactique, de polyamide, de viscose, de cellulose ou d'un mélange de ces fibres ... ou un film, pouvant être perméable ou non. Les non tissés sont décrits de façon générale dans RIEDEL « Nonwoven Bonding Methods & Materials », Nonwoven World (1987), incorporé ici par référence.The
Une structure multicouche avec au moins une couche formée d'un substrat insoluble dans l'eau peut par exemple être utile pour réaliser un article 22 comportant un support 23 en forme de doigt de gant, comme illustré à la figure 10 (qui est une perspective schématique), un tel article étant destiné par exemple à l'hygiène bucco-dentaire. La couche formée de fibres hydrosolubles est située à l'extérieur de l'article, étant destinée à se solubiliser lors de l'utilisation, après avoir été mouillée ou en venant au contact d'une région mouillée du corps.A multilayer structure with at least one layer formed of a water-insoluble substrate may for example be useful for producing an
La couche 20 de substrat insoluble peut encore présenter la forme d'un gant ou d'une moufle.The
Lorsque le support comporte plusieurs couches, que celles-ci soient toutes réalisées avec des fibres hydrosolubles ou non, les différentes couches peuvent être assemblées de multiples manières, par exemple par soudage, collage ou couture, et ces couches peuvent constituer le cas échéant une ou plusieurs cavités contenant une ou plusieurs compositions cosmétiques ou dermatologiques ou plusieurs composants d'une même composition cosmétique à mélanger extemporanément. Lors d'un assemblage par couture, un fil lui-même hydrosoluble peut être utilisé, le cas échéant.When the support comprises several layers, whether all these are made with water-soluble or non-water-soluble fibers, the different layers can be assembled in multiple ways, for example by welding, gluing or sewing, and these layers can constitute, where appropriate, one or several cavities containing one or more cosmetic or dermatological compositions or several components of the same cosmetic composition to be mixed extemporaneously. When sewing together, a water-soluble yarn can be used, if necessary.
Comme indiqué plus haut, le support peut comporter, voire être constitué essentiellement, par des fibres solubles, de préférence dans l'eau à moins de 20 °C.As indicated above, the support may comprise, or even consist essentially of, soluble fibers, preferably in water at less than 20 ° C.
Le support peut ainsi comporter, par exemple, plus de 95 % en masse, voire plus de 99 % ou davantage encore de fibres hydrosolubles.The support may thus comprise, for example, more than 95% by weight, or even more than 99% or more of water-soluble fibers.
De préférence, les fibres sont réalisées avec de l'alcool polyvinylique (PVA) selon un procédé qui leur confère la solubilité recherchée.Preferably, the fibers are made with polyvinyl alcohol (PVA) according to a process which gives them the desired solubility.
Des fibres solubles dans l'eau à une température inférieure à 20 °C sont commercialisées par la société japonaise KURARAY sous la dénomination commerciale KURALON K-II WN2. Le procédé de fabrication de ces fibres comporte l'emploi de solvants organiques. La section de ces fibres peut être sensiblement circulaire.Fibers soluble in water at a temperature below 20 ° C are marketed by the Japanese company KURARAY under the trade name KURALON K-II WN2. The process for producing these fibers involves the use of organic solvents. The section of these fibers may be substantially circular.
La demande EP 0 636 716, dont le contenu est incorporé à la présente par référence, décrit des fibres hydrosolubles à base de PVA et leur procédé de fabrication.EP 0 636 716, the contents of which are hereby incorporated by reference, discloses water-soluble PVA-based fibers and their method of manufacture.
L'invention n'est pas limitée à l'emploi de PVA et des fibres réalisées dans d'autres matériaux hydrosolubles peuvent être utilisées sous réserve de se dissoudre dans de l'eau ayant la température recherchée, par exemple des fibresde polysaccharides commercialisées sous la dénomination LYSORB par la société LYSAC TECHNOLOGIES, INC ou des fibres à base de polymères polyholosides comme le glucomannane ou l'amidon.The invention is not limited to the use of PVA and fibers made in other water-soluble materials can be used provided they dissolve in water having the desired temperature, for example polysaccharide fibers marketed under the LYSORB denomination by the company LYSAC TECHNOLOGIES, INC or fibers based on polysaccharide polymers such as glucomannan or starch.
Le support peut comporter, le cas échéant, un mélange de fibres solubles dans l'eau à des températures différentes.The support may comprise, where appropriate, a mixture of fibers soluble in water at different temperatures.
Les fibres peuvent être composites, et comporter par exemple un coeur et une gaine n'ayant pas la même nature, par exemple formés de différents grades de PVA.The fibers may be composite, and include for example a core and a sheath of the same nature, for example formed of different grades of PVA.
Le support peut être sensiblement dépourvu de fibres insolubles dans l'eau.The support may be substantially free of insoluble fibers in the water.
Selon un aspect de l'invention, le support est dépourvu d'adhésif, notamment d'adhésif sensible à la pression.According to one aspect of the invention, the support is devoid of adhesive, especially pressure-sensitive adhesive.
Des composés très divers peuvent être utilisés dans un article réalisé conformément à l'invention.A wide variety of compounds can be used in an article made in accordance with the invention.
Il peut s'agir par exemple de composés destinés au maquillage, au soin et/ou à l'hygiène et/ou au nettoyage de la peau, de la bouche, des muqueuses ou des phanères.It may be for example compounds intended for makeup, care and / or hygiene and / or cleaning the skin, mouth, mucous membranes or integuments.
La composition cosmétique ou dermatologique portée par le support peut représenter par exemple entre 10 et 1000 % en poids, par rapport au poids du support.The cosmetic or dermatological composition carried by the support may for example represent between 10 and 1000% by weight, relative to the weight of the support.
L'article peut comporter au moins un actif cosmétique ou dermatologique.The article may comprise at least one cosmetic or dermatological active ingredient.
Comme actifs, on peut citer par exemple, sans que cette liste ne soit limitative, les actifs antiséborrhéiques qui permettent un nettoyage de l'excédent de sebum sur la peau, et les agents antimicrobiens qui éliminent de la peau les microorganismes qui y sont éventuellement présents, et leurs mélanges.As active agents, there may be mentioned, for example, without this list being limiting, the antiseborrhoeic active agents which make it possible to clean the excess of sebum on the skin, and the antimicrobial agents which remove from the skin the microorganisms that may be present therein. , and their mixtures.
Comme actifs antiséborrhéiques, on peut citer par exemple le soufre et les dérivés soufrés, le peroxyde de benzoyle, les dérivés de zinc tels que le sulfate de zinc et l'oxyde de zinc, le chlorure d'aluminium, le disulfure de sélénium, les vitamines B et notamment le panthénol (vitamine B5) et la niacinamide (vitamine B6 ou PP), et leurs mélanges.Examples of antiseborrhoeic active agents that may be mentioned include sulfur and sulfur derivatives, benzoyl peroxide, zinc derivatives such as zinc sulphate and zinc oxide, aluminum chloride, selenium disulphide, B vitamins and in particular panthenol (vitamin B5) and niacinamide (vitamin B6 or PP), and mixtures thereof.
Comme antimicrobiens, on peut citer par exemple les actifs suivants : dérivés de β-lactam, dérivés de quinolone, ciprofloxacine, norfloxacine, tétracycline et ses sels (chlorhydrate), érythromycine et ses sels (de zinc, estolate, stéarate), amikacine et ses sels (sulfate), 2,4,4'-trichloro-2'-hydroxy diphenyl éther (triclosan), 3,4,4'-trichlorobanilide (tricarban), phénoxyéthanol, phénoxypropanol, phénoxyisopropanol, doxycycline et ses sels (chlorhydrate), capréomycine et ses sels (sulfate), chlorhexidine et ses sels (gluconate, chlorhydrate), chlorotétracycline et ses sels (chlorhydrate), oxytétracycline et ses sels (chlorhydrate), clindamycine et ses sels (chlorhydrate), éthambutol et ses sels (chlorhydrate), hexamidine et ses sels (iséthionate), métronidazole et ses sels (chlorhydrate), pentamidine et ses sels (chlorhydrate), gentamicine et ses sels (sulfate), kanamycine et ses sels (sulfate), linéomycine et ses sels (chlorhydrate), méthacycline et ses sels (chlorhydrate), méthenamine et ses sels (hippurate, mandelate), minocycline et ses sels (chlorhydrate), néomycine et ses sels (sulfate), netilmicine et ses sels (sulfate), paromomycine et ses sels (sulfate), streptomycine et ses sels (sulfate), tobramycine et ses sels (sulfate), miconazole et ses sels (chlorhydrate), amanfadine et ses sels (sulfate, chlorhydrate), octopirox, parachlorometaxylenol, nystatine, tolnaftate, zinc pyrithione, clotrimazole, acide salicylique, acide n-octanoyl-5 salicylique (ou acide capryloylsalicylique), peroxyde de benzoyle, acide 3-hydroxybenzoique, acide glycolique, acide lactique, acide 4-hydroxy-benzoique, acide acétylsalicylique, acide 2-hydroxybutanoique, acide 2-hydroxypentanoique, acide 2-hydroxyhexanoique, acide phytique , acide N-acetyl-L-cysteine, acide lipoique, acide azélaïque, acide arachidonique, ibuprofen, naproxen, hydrocortisone, acetominophen, resorcinol, chlorhydrate de lidocaine, sulfate de néocycine, octoxyglycérine, octanoylglycine (ou capryloylglycine), caprylylglycol (1,2-octanediol), acide 10-hydroxy-2-décanoique, et leurs mélanges. Les agents antimicrobiens préférés sont le 2,4,4'-trichloro-2'-hydroxy diphenyl éther, le 3,4,4'-trichlorobanilide, le phénoxyéthanol, le phénoxypropanol, le phénoxyisopropanol, la chlorhexidine et ses sels, l'octopirox, le zinc pyrithione, l'acide salicylique, l'acide n-octanoyl-5 salicylique, le peroxyde de benzoyle, l'acide 3-hydroxybenzoique, l'acide glycolique, l'acide lactique, l'acide 4-hydroxy-benzoique, l'acide acétylsalicylique, l'acide 2-hydroxybutanoique, l'acide 2-hydroxypentanoique, l'acide 2-hydroxyhexanoique, l'acide phytique , l'acide N-acetyl-L-cysteine, l'acide lipoique, l'acide azélaïque, l'acide arachidonique, l'octoxyglycérine, l'octanoylglycine, le caprylylglycol, l'acide 10-hydroxy-2-décanoique, et leurs mélanges.Examples of antimicrobials that may be mentioned include: β-lactam derivatives, quinolone derivatives, ciprofloxacin, norfloxacin, tetracycline and its salts (hydrochloride), erythromycin and its salts (zinc, estolate, stearate), amikacin and its salts (sulphate), 2,4,4'-trichloro-2'-hydroxy diphenyl ether (triclosan), 3,4,4'-trichlorobanilide (tricarban), phenoxyethanol, phenoxypropanol, phenoxyisopropanol, doxycycline and its salts (hydrochloride), careomycin and its salts (sulphate), chlorhexidine and its salts (gluconate, hydrochloride), chlorotetracycline and its salts (hydrochloride), oxytetracycline and its salts (hydrochloride), clindamycin and its salts (hydrochloride), ethambutol and its salts (hydrochloride), hexamidine and its salts (isethionate), metronidazole and its salts (hydrochloride), pentamidine and its salts (hydrochloride), gentamicin and its salts (sulphate), kanamycin and its salts (sulphate), linomycin and its salts (hydrochloride), methacycline and its salts (chl orhydrate), methenamine and its salts (hippurate, mandelate), minocycline and its salts (hydrochloride), neomycin and its salts (sulphate), netilmicin and its salts (sulphate), paromomycin and its salts (sulphate), streptomycin and its salts (sulphate), tobramycin and its salts (sulphate), miconazole and its salts (hydrochloride ), amanfadine and its salts (sulfate, hydrochloride), octopirox, parachlorometaxylenol, nystatin, tolnaftate, zinc pyrithione, clotrimazole, salicylic acid, 5-n-octanoyl salicylic acid (or capryloylsalicylic acid), benzoyl peroxide, 3-hydroxybenzoic acid, glycolic acid, lactic acid, 4-hydroxybenzoic acid, acetylsalicylic acid, 2-hydroxybutanoic acid, 2-hydroxypentanoic acid, 2-hydroxyhexanoic acid, phytic acid, N-acetyl-L-cysteine acid, lipoic acid, azelaic acid, acid arachidonic, ibuprofen, naproxen, hydrocortisone, acetominophen, resorcinol, lidocaine hydrochloride, neocycine sulfate, octoxyglycerine, octanoylglycine (or capryloylglycine), caprylylglycol (1,2-octanediol), 10-hydroxy-2-decanoyl acid ue, and their mixtures. The preferred antimicrobial agents are 2,4,4'-trichloro-2'-hydroxy diphenyl ether, 3,4,4'-trichlorobanilide, phenoxyethanol, phenoxypropanol, phenoxyisopropanol, chlorhexidine and its salts, octopirox , zinc pyrithione, salicylic acid, 5-n-octanoyl salicylic acid, benzoyl peroxide, 3-hydroxybenzoic acid, glycolic acid, lactic acid, 4-hydroxybenzoic acid , acetylsalicylic acid, 2-hydroxybutanoic acid, 2-hydroxypentanoic acid, 2-hydroxyhexanoic acid, phytic acid, N-acetyl-L-cysteine acid, lipoic acid, azelaic acid, arachidonic acid, octoxyglycerine, octanoylglycine, caprylylglycol, 10-hydroxy-2-decanoic acid, and mixtures thereof.
La composition peut comporter des actifs agissants sur la fonction barrière de la peau, des actifs favorisant l'hydratation de la peau et des agents desquamants.The composition may comprise active agents acting on the barrier function of the skin, active agents that promote the hydration of the skin and desquamating agents.
Par « agent desquamant », on entend tout composé capable d'agir :
- soit directement sur la desquamation en favorisant l'exfoliation, tel que les β-hydroxyacides, en particulier l'acide salicylique et ses dérivés (dont l'acide n-octanoyl 5-salicylique) ; les α-hydroxyacides, tels que les acides glycolique, citrique, lactique, tartrique, malique ou mandélique ; l'urée ; l'acide gentisique ; les oligofucoses ; l'acide cinnamique ; l'extrait de Saphora japonica ; le resvératrol ;
- sur les enzymes impliquées dans la desquamation ou la dégradation des cornéodesmosomes, telles que les glycosidases, la stratum corneum chymotryptic enzym (SCCE) voire d'autres protéases (trypsine, chymotrypsine-like). On peut citer les agents chélatant des sels minéraux : l'EDTA ; l'acide N-acyl-N,N',N' éthylène diaminetriacétique ; les composés aminosulfoniques et en particulier l'acide N-(2-hydroxyéthyl)pipérazine-N'-2-éthane sulfonique (HEPES) ; les dérivés de l'acide 2-oxothiazolidine-4-carboxylique (procystéine) ; les dérivés d'acides alpha aminés de type glycine (tels que décrits dans EP-0 852 949, ainsi que le méthyl glycine diacétate de sodium commercialisé par BASF sous la dénomination commerciale « TRILON M ») ; le miel ; les dérivés de sucre tels que l'O-octanoyl-6-D-maltose et la N-acétyl glucosamine.
- either directly on desquamation by promoting exfoliation, such as β-hydroxy acids, in particular salicylic acid and its derivatives (including n-octanoyl 5-salicylic acid); α-hydroxy acids, such as glycolic, citric, lactic, tartaric, malic or mandelic acids; urea; gentisic acid; oligofucoses; cinnamic acid; Saphora japonica extract; resveratrol;
- on enzymes involved in the desquamation or degradation of corneodesmosomes, such as glycosidases, stratum corneum chymotryptic enzyme (SCCE) or even other proteases (trypsin, chymotrypsin-like). We can mention the agents chelating mineral salts: EDTA; N-acyl-N, N ', N', ethylene diaminetriacetic acid; aminosulfonic compounds and in particular N- (2-hydroxyethyl) piperazine-N'-2-ethanesulfonic acid (HEPES); 2-oxothiazolidine-4-carboxylic acid derivatives (procysteine); derivatives of alpha amino acids of the glycine type (as described in EP-0 852 949, as well as the sodium methyl glycine diacetate marketed by BASF under the trade name "Trilon M");honey; sugar derivatives such as O-octanoyl-6-D-maltose and N-acetyl glucosamine.
Parmi les actifs agissant sur la fonction barrière de la peau, ou favorisant l'hydratation de la peau, on peut citer :
- les composés agissant sur la fonction barrière, en vue de maintenir l'hydratation du stratum corneum, ou les composés occlusifs, en particulier les céramides, les composés à base sphingoïde, les lécithines, les glycosphingolipides, les phospholipides, le cholestérol et ses dérivés, les phytostérols (stigmastérol, β-sitostérol, campestérol), les acides gras essentiels, le 1-2 diacylglycérol, la 4-chromanone, les triterpènes pentacycliques tels que l'acide ursolique, la vaseline et la lanoline ;
- les composés augmentant directement la teneur en eau du stratum corneum, tel que le thréalose et ses dérivés, l'acide hyaluronique et ses dérivés, le glycérol, le pentanediol, le pidolate de sodium, la sérine, le xylitol, le lactate de sodium, le polyacrylate de glycérol, l'ectoïne et ses dérivés, le chitosane, les oligo- et polysaccharides, les carbonates cycliques, l'acide N-lauroyl pyrrolidone carboxylique, et la N-α-benzoyl-L-arginine.
- compounds acting on the barrier function, with a view to maintaining hydration of the stratum corneum, or occlusive compounds, in particular ceramides, sphingoid-based compounds, lecithins, glycosphingolipids, phospholipids, cholesterol and its derivatives, phytosterols (stigmasterol, β-sitosterol, campesterol), essential fatty acids, 1-2 diacylglycerol, 4-chromanone, pentacyclic triterpenes such as ursolic acid, petrolatum and lanolin;
- compounds directly increasing the water content of the stratum corneum, such as thralose and its derivatives, hyaluronic acid and its derivatives, glycerol, pentanediol, sodium pidolate, serine, xylitol, sodium lactate, glycerol polyacrylate, ectoin and its derivatives, chitosan, oligo- and polysaccharides, cyclic carbonates, N-lauroyl pyrrolidone carboxylic acid, and N-α-benzoyl-L-arginine.
Comme actifs cosmétiques, dermatologiques ou hygiéniques, on peut encore citer les vitamines (C, A, E, F, B, ou PP), les acides gras essentiels, les huiles essentielles, les filtres solaires, notamment liposolubles ou sous forme de nano-particules, les actifs spécifiques de traitement de la peau (anti-odeurs, anti-rides...), les autobronzants, tous extraits végétaux, minéraux ou marins, les substances antiradicalaires ou apaisantes, les substances amincissantes (caféine, ...). Tous ces actifs peuvent être utilisés par exemple à des concentrations de 0 à 20 % et notamment de 0,001 à 15 %, par rapport au poids total de la composition.As cosmetic, dermatological or hygienic active agents, mention may also be made of vitamins (C, A, E, F, B, or PP), essential fatty acids, essential oils, sunscreens, especially liposoluble or in the form of nanoparticles. particles, specific skin treatment active ingredients (anti-odor, anti-wrinkle, etc.), self-tanning agents, all plant extracts, mineral or marine extracts, antiradical or soothing substances, slimming substances (caffeine, etc.) . All these active ingredients can be used, for example, at concentrations of 0 to 20% and in particular from 0.001 to 15%, relative to the total weight of the composition.
Toute ou partie des actifs peut être encapsulée, le cas échéant.All or part of the assets may be encapsulated, if any.
L'article peut comporter au moins un agent de coloration, en quantité comprise entre 0 et 100%, par exemple entre 0 à 95 %, de préférence entre 0,1 à 50 %, et mieux de 1 à 25 % du poids total de la composition, notamment au moins un pigment ou colorant, par exemple un agent de coloration choisi parmi les pigments minéraux, les pigments ou laques organiques, les pigments nacrés, les pigments composites, les colorants liposolubles et hydrosolubles.The article may comprise at least one coloring agent, in an amount of between 0 and 100%, for example between 0 to 95%, preferably between 0.1 to 50%, and better still from 1 to 25% of the total weight of the composition, especially at least one pigment or dye, for example a coloring agent chosen from inorganic pigments, organic pigments or lakes, pearlescent pigments, composite pigments, fat-soluble and water-soluble dyes.
Les pigments minéraux peuvent être enrobés ou non. On peut citer le dioxyde de titane, éventuellement traité en surface, les oxydes de zirconium ou de cérium, ainsi que les oxydes de fer ou de chrome, le violet de manganèse, le bleu outremer, l'hydrate de chrome et le bleu ferrique.The mineral pigments can be coated or not. Titanium dioxide, optionally surface-treated, oxides of zirconium or cerium, as well as iron or chromium oxides, manganese violet, ultramarine blue, chromium hydrate and ferric blue may be mentioned.
Les pigments nacrés peuvent être choisis parmi les pigments nacrés blancs tels que le mica recouvert de titane ou d'oxychlorure de bismuth, les pigments nacrés colorés tels que le mica titane avec des oxydes de fer, le mica titane avec notamment du bleu ferrique ou de l'oxyde de chrome, les nacres de couleur or telles que commercialisées par la société ENGELHARD sous le nom de Brillant gold 212G (Timica), Gold 222C (Cloisonne), Sparkle gold (Timica), Gold 4504 (Chromalite) et Monarch gold 233X (Cloisonne) ; les nacres bronzes notamment commercialisées par la société MERCK sous la dénomination Bronze fine (17384) (Colorona) et Bronze (17353) (Colorona) et par la société ENGELHARD sous la dénomination Super bronze (Cloisonne) ; les nacres oranges notamment commercialisées par la société ENGELHARD sous la dénomination Orange 363C (Cloisonne) et Orange MCR 101 (Cosmica) et par la société MERCK sous la dénomination Passion orange (Colorona) et Matte orange (17449) (Microna) ; les nacres de teinte brune notamment commercialisées par la société ENGELHARD sous la dénomination Nu-antique copper 340XB (Cloisonne) et Brown CL4509 (Chromalite) ; les nacres à reflet cuivre notamment commercialisées par la société ENGELHARD sous la dénomination Copper 340A (Timica) ; les nacres à reflet rouge notamment commercialisées par la société MERCK sous la dénomination Sienna fine (17386) (Colorona) ; les nacres à reflet jaune notamment commercialisées par la société ENGELHARD sous la dénomination Yellow (4502) (Chromalite) ; les nacres de teinte rouge à reflet or notamment commercialisées par la société ENGELHARD sous la dénomination Sunstone G012 (Gemtone) ; les nacres roses notamment commercialisées par la société ENGELHARD sous la dénomination Tan opale G005 (Gemtone) ; les nacres noires à reflet or notamment commercialisées par la société ENGELHARD sous la dénomination Nu antique bronze 240 AB (Timica), les nacres bleues notamment commercialisées par la société MERCK sous la dénomination Matte blue (17433) (Microna), les nacres blanches à reflet argenté notamment commercialisées par la société MERCK sous la dénomination Xirona Silver et les nacres orangées rosées vert doré notamment commercialisées par la société MERCK sous la dénomination Indian summer (Xirona) et leurs mélanges. Les colorants liposolubles sont par exemple des extraits végétaux, le rouge Soudan, le DC Red 17, le DC Green 6, le β-carotène, l'huile de soja, le brun Soudan, le DC Yellow 11, le DC Violet 2, le DC orange 5, le jaune quinoléine.The pearlescent pigments may be chosen from white pearlescent pigments such as mica coated with titanium or bismuth oxychloride, colored pearlescent pigments such as titanium mica with iron oxides, titanium mica with in particular ferric blue or with chromium oxide, gold-colored mother-of-pearls as sold by the company Engelhard under the name Brilliant gold 212G (Timica), Gold 222C (Cloisonne), Sparkle gold (Timica), Gold 4504 (Chromalite) and Monarch gold 233X (Cloisonne); bronze nacres sold especially by the company Merck under the name Bronze Fine (17384) (Colorona) and Bronze (17353) (Colorona) and by Engelhard under the name Super Bronze (Cloisonne); orange nacres sold especially by the company Engelhard under the name Orange 363C (Cloisonne) and Orange MCR 101 (Cosmica) and by the company Merck under the name Passion Orange (Colorona) and Matte Orange (17449) (Microna); brown-colored pearlescent agents marketed by Engelhard under the name Nu-antique copper 340XB (Cloisonne) and Brown CL4509 (Chromalite); nacres with a copper sheen sold especially by Engelhard under the name Copper 340A (Timica); the nacres with a red glint sold especially by MERCK under the name Sienna fine (17386) (Colorona); yellow-colored pearlescent agents marketed by ENGELHARD under the name Yellow (4502) (Chromalite); the red-colored pearlescent agents with a gold glint sold especially by ENGELHARD under the name Sunstone G012 (Gemtone); pink nacres marketed in particular by ENGELHARD under the name Tan opal G005 (Gemtone); the black nacres with gold reflection sold by the company Engelhard under the name Nu antique bronze 240 AB (Timica), the blue nacres sold especially by the company Merck under the name Matte Blue (17433) (Microna), the white nacres with reflection silver sold in particular by the company Merck under the name Xirona Silver and the golden-green orange-colored mother-of-pearl marketed by Merck under the name Indian summer (Xirona) and their mixtures. The fat-soluble dyes are, for example, plant extracts, Sudan Red, DC Red 17,
Les colorants hydrosolubles sont choisis par exemple parmi les extraits végétaux, notamment le jus de betterave et le bleu de méthylène.The water-soluble dyes are chosen for example from plant extracts, in particular beet juice and methylene blue.
L'agent de coloration peut comporter au moins une matière colorante organique, par exemple au moins un pigment organique et/ou au moins une laqueorganique.The coloring agent may comprise at least one organic dyestuff, for example at least one organic pigment and / or at least one organic lacquer.
La matière colorante organique peut comporter par exemple des pigments ou laques organiques qui peuvent être choisis parmi les composés ci-dessous et leurs mélanges :
- le carmin de cochenille,
- les pigments organiques de colorants azoïques, anthraquinoniques, indigoïdes, xanthéniques, pyréniques, quinoliniques, de triphénylméthane, de fluorane,
- les laques organiques ou sels insolubles de sodium, de potassium, de calcium, de baryum, d'aluminium, de zirconium, de strontium, de titane, de colorants acides tels que les colorants azoïques, anthraquinoniques, indigoïdes, xanthéniques, pyréniques, quinoliniques, de triphénylméthane, de fluorane, ces colorants pouvant comporter au moins un groupe acide carboxylique ou sulfonique.
- carmine of cochineal,
- the organic pigments of azo, anthraquinone, indigo, xanthene, pyrenic, quinoline, triphenylmethane and fluoran dyes,
- organic lakes or insoluble salts of sodium, potassium, calcium, barium, aluminum, zirconium, strontium, titanium, acid dyes such as azo, anthraquinone, indigo, xanthene, pyrenic, quinoline dyes, triphenylmethane, fluoran, these dyes may comprise at least one carboxylic or sulfonic acid group.
Parmi les pigments organiques, on peut notamment citer ceux connus sous les dénominations suivantes : D&C Blue n° 4, D&C Brown n° 1, D&C Green n° 5, D&C Green n° 6, D&C Orange n° 4, D&C Orange n° 5, D&C Orange n° 10, D&C Orange n° 11, D&C Red n° 6, D&C Red n° 7, D&C Red n° 17, D&C Red n° 21, D&C Red n° 22, D&C Red n° 27, D&C Red n° 28, D&C Red n° 30, D&C Red n° 31, D&C Red n° 33, D&C Red n° 34, D&C Red n° 36, D&C Violet n° 2, D&C Yellow n° 7, D&C Yellow n° 8, D&C Yellow n° 10, D&C Yellow n° 11, FD&C Blue n° 1, FD&C Green n° 3, FD&C Red n° 40, FD&C Yellow n° 5, FD&C Yellow n° 6.Among the organic pigments, mention may be made of those known under the following names: D & C Blue No. 4, D & C Brown No. 1, D & C Green No. 5, D & C Green No. 6, D & C Orange No. 4, D & C Orange No. 5, D & C Orange No. 10, D & C Orange No. 11, D & C Red No. 6, D & C Red No. 7, D & C Red No. 17, D & C Red No. 21, D & C Red No. 22, D & C Red No. 27, D & C Red No. 28, D & C Red No. 30, D & C Red No. 31, D & C Red No. 33, D & C Red No. 34, D & C Red No. 36, D & C Violet No. 2, D & C Yellow No. 7, D & C Yellow n ° 8, D &
La matière colorante organique peut comporter une laque organique supportée par un support organique tel que la colophane ou le benzoate d'aluminium, par exemple.The organic dyestuff may comprise an organic lacquer supported by an organic support such as rosin or aluminum benzoate, for example.
Parmi les laques organiques, on peut en particulier citer celles connues sous les dénominations suivantes : D&C Red n° 2 Aluminium lake, D&C Red n° 3 Aluminium lake, D&C Red n° 4 Aluminium lake, D&C Red n° 6 Aluminium lake, D&C Red n° 6 Barium lake, D&C Red n° 6 Barium/Strontium lake, D&C Red n° 6 Strontium lake, D&C Red n° 6 Potassium lake, D&C Red n° 7 Aluminium lake, D&C Red n° 7 Barium lake, D&C Red n° 7 Calcium lake, D&C Red n° 7 Calcium/Strontium lake, D&C Red n° 7 Zirconium lake, D&C Red n° 8 Sodium lake, D&C Red n° 9 Aluminium lake, D&C Red n° 9 Barium lake, D&C Red n° 9 Barium/Strontium lake, D&C Red n° 9 Zirconium lake, D&C Red n° 10 Sodium lake, D&C Red n° 19 Aluminium lake, D&C Red n° 19 Barium lake, D&C Red n° 19 Zirconium lake, D&C Red n° 21 Aluminium lake, D&C Red n° 21 Zirconium lake, D&C Red n° 22 Aluminium lake, D&C Red n° 27 Aluminium lake, D&C Red n° 27 Aluminium/Titanium/Zirconium lake, D&C Red n° 27 Barium lake, D&C Red n° 27 Calcium lake, D&C Red n° 27 Zirconium lake, D&C Red n° 28 Aluminium lake, D&C Red n° 30 lake, D&C Red n° 31 Calcium lake, D&C Red n° 33 Aluminium lake, D&C Red n° 34 Calcium lake, D&C Red n° 36 lake, D&C Red n° 40 Aluminium lake, D&C Blue n° 1 Aluminium lake, D&C Green n° 3 Aluminium lake, D&C Orange n° 4 Aluminium lake, D&C Orange n° 5 Aluminium lake, D&C Orange n° 5 Zirconium lake, D&C Orange n° 10 Aluminium lake, D&C Orange n° 17 Barium lake, D&C Yellow n° 5 Aluminium lake, D&C Yellow n° 5 Zirconium lake, D&C Yellow n° 6 Aluminium lake, D&C Yellow n° 7 Zirconium lake, D&C Yellow n° 10 Aluminium lake, FD&C Blue n° 1 Aluminium lake, FD&C Red n° 4 Aluminium lake, FD&C Red n° 40 Aluminium lake, FD&C Yellow n° 5 Aluminium lake, FD&C Yellow n° 6 Aluminium lake.Among the organic lakes, mention may be made in particular of the following denominations: D & C Red No. 2 Aluminum Lake, D & C Red No. 3 Aluminum Lake, D & C Red No. 4 Aluminum Lake, D & C Red No. 6 Aluminum Lake, D & C Red # 6 Barium Lake, D & C Red # 6 Barium / Strontium Lake, D & C Red # 6 Strontium Lake, D & C Red # 6 Potassium Lake, D & C Red # 7 Aluminum Lake, D & C Red # 7 Barium Lake, D & C Red # 7 Calcium Lake, D & C Red # 7 Calcium / Strontium Lake, D & C Red # 7 Zirconium Lake, D & C Red # 8 Sodium Lake, D & C Red # 9 Aluminum Lake, D & C Red # 9 Barium Lake, D & C Red # 9 Barium / Strontium Lake, D & C Red # 9 Zirconium Lake, D & C Red # 10 Sodium Lake, D & C Red # 19 Aluminum Lake, D & C Red # 19 Barium Lake, D & C Red # 19 Zirconium Lake, D & C Red # 21 Aluminum Lake, D & C Red # 21 Zirconium Lake, D & C Red # 22 Aluminum Lake, D & C Red # 27 Aluminum Lake, D & C Red # 27 Aluminum / Titanium / Zirconium Lake, D & C Red # 27 Barium Lake , D & C Red # 27 Calcium Lake, D & C Red # 27 Zirconium Lake, D & C Red # 28 Aluminum Lake, D & C Red # 30 Lake, D & C Red # 31 Calcium Lake, D & C Red # 33 Aluminum Lake, D & C Red # 34 Calcium Lake, D & C Red # 36 Lake, D & C Red # 40 Aluminum Lake, D & C Blue # 1 Aluminum Lake, D & C Green # 3 Aluminum Lake, D & C Orange # 4 Aluminum Lake, D & C Orange # 5 Aluminum Lake, D & C Orange # 5 Zirconium Lake, D & C Orange No. 10 Aluminum Lake, D & C Orange No. 17 Barium Lake, D & C Yellow No. 5 Aluminum Lake, D & C Yellow No. 5 Zirconium Lake, D & C Yellow No. 6 Aluminum Lake, D & C Yellow No. 7 Zirconium Lake, D & C Yellow # 10 Aluminum Lake, FD & C Blue # 1 Aluminum Lake, FD & C Red # 4 Aluminum Lake, FD & C Red # 40 Aluminum Lake, FD & C Yellow # 5 Aluminum Lake, FD & C Yellow # 6 Aluminum Lake.
Les composés correspondant à chacune des matières colorantes organiques citées précédemment sont mentionnés dans l'ouvrage « International Cosmetic Ingredient Dictionnary and Handbook », Edition 1997, pages 371 à 386 et 524 à 528, publié par « The Cosmetic, Toiletry, and Fragrance Association », dont le contenu est incorporé dans la présente demande par référence.The compounds corresponding to each of the organic dyestuffs mentioned above are mentioned in the "International Cosmetic Ingredient Dictionary and Handbook", Edition 1997, pages 371 to 386 and 524 to 528, published by The Cosmetic, Toiletry, and Fragrance Association. , the contents of which are incorporated herein by reference.
L'article peut comporter au moins un agent de coloration goniochromatique.The article may comprise at least one goniochromatic coloring agent.
L'agent de coloration goniochromatique peut être choisi par exemple parmi les structures multicouche interférentielles et les agents de coloration à cristaux liquides, par exemple Fe2O3/SiO2/Fe2O3/SiO2/Fe2O3, un pigment ayant cette structure étant commercialisé sous la dénomination SICOPEARL par la société BASF, MoS2/SiO2/mica-oxyde/SiO2/MoS2, Fe2O3/SiO2/mica-oxyde/SiO2/Fe2O3, TiO2/SiO2/TiO2 ou TiO2/Al2O3/TiO2, des pigments ayant ces structures étant commercialisés sous la dénomination XIRONA par la société MERCK (Darmstadt).The goniochromatic coloring agent may be chosen for example from interferential multilayer structures and liquid crystal coloring agents, for example Fe 2 O 3 / SiO 2 / Fe 2 O 3 / SiO 2 / Fe 2 O 3 , a pigment having this structure being marketed under the name SICOPEARL by BASF, MoS 2 / SiO 2 / mica-oxide / SiO 2 / MoS 2 , Fe 2 O 3 / SiO 2 / mica-oxide / SiO 2 / Fe 2 O 3 , TiO 2 / SiO 2 / TiO 2 or TiO 2 / Al 2 O 3 / TiO 2 , pigments having these structures being sold under the name XIRONA by the company Merck (Darmstadt).
L'agent de coloration peut encore comporter un pigment diffractant, présentant par exemple la structure MgF2/Al/MgF2, tel que commercialisé sous la dénomination SPECTRAFLAIR 1400 Pigment Silver par la société FLEX PRODUCTS, ou SPECTRAFLAIR 1400 Pigment Silver FG.The coloring agent may also comprise a diffractive pigment having, for example, the MgF 2 / Al / MgF 2 structure , as sold under the name SPECTRAFLAIR 1400 Pigment Silver by the company FLEX PRODUCTS, or SPECTRAFLAIR 1400 Pigment Silver FG.
Quelle que soit la nature des pigments utilisés, l'article peut comporter outre la phase particulaire comportant les pigments au moins un liant comprenant au moins un organopolysiloxane hydrophile solide élastomérique. Des exemples de tels polymères sont donnés dans la demande US 2004/0071648 dont le contenu est incorporé à la présente par référence.Whatever the nature of the pigments used, the article may comprise, in addition to the particulate phase comprising the pigments, at least one binder comprising at least one elastomeric solid hydrophilic organopolysiloxane. Examples of such polymers are given in US 2004/0071648, the contents of which are hereby incorporated by reference.
L'article peut comporter un ou plusieurs agents filmogènes, par exemple lorsqu'il est destiné au maquillage ou à former un film pelable ou un masque de soin.The article may comprise one or more film-forming agents, for example when it is intended for make-up or for forming a peelable film or a care mask.
Le support lui-même peut servir d'agent filmogène après dissolution, notamment lorsque le support est réalisé en PVA.The support itself can serve as a film-forming agent after dissolution, especially when the support is made of PVA.
Le support peut ainsi être en une quantité suffisante pour permettre la formation d'un film continu sur des matières kératiniques.The support can thus be in an amount sufficient to allow the formation of a continuous film on keratin materials.
L'article peut comporter d'autres agents filmogènes, lesquels pourront être choisis en fonction par exemple de la nature du support.The article may comprise other film-forming agents, which may be chosen as a function, for example, of the nature of the support.
Ces autres agents filmogènes peuvent être choisis parmi les polymères synthétiques, de type radicalaire ou de type polycondensat, les polymères d'origine naturelle, et leurs mélanges.These other film-forming agents may be chosen from synthetic polymers, of radical type or of polycondensate type, polymers of natural origin, and their mixtures.
Les polymères filmogènes de type radicalaire peuvent être par exemple des polymères ou des copolymères vinyliques, notamment des polymères acryliques.The radical-type film-forming polymers may be, for example, vinyl polymers or copolymers, in particular acrylic polymers.
Les polymères filmogènes vinyliques peuvent résulter de la polymérisation de monomères à insaturation éthylénique ayant au moins un groupement acide et/ou des esters de ces monomères acides et/ou des amides de ces monomères acides comme les acides carboxyliques insaturés α,β-éthyléniques.The vinyl film-forming polymers may result from the polymerization of ethylenically unsaturated monomers having at least one acid group and / or esters of these acid monomers and / or amides of these acidic monomers such as α, β-ethylenic unsaturated carboxylic acids.
Parmi les polycondensats filmogènes, on peut citer les polyuréthanes, les polyesters, les polyesters amides, les polyamides, et les polyurées, cette liste n'étant pas limitative.Among the film-forming polycondensates, there may be mentioned polyurethanes, polyesters, polyesters amides, polyamides, and polyureas, this list not being limiting.
Les polymères d'origine naturelle, éventuellement modifiés, peuvent être choisis parmi la résine shellac, la gomme de sandaraque, les dammars, les élémis, les copals, les polymères cellulosiques.The polymers of natural origin, optionally modified, may be selected from shellac resin, sandarac gum, dammars, elemis, copal, cellulosic polymers.
L'article peut également contenir tous ingrédients couramment utilisés en cosmétique ou dermatologie et physiologiquement acceptables, tels que par exemple des charges, épaississants, des tensioactifs, des oligo-éléments, des séquestrants, des parfums, des agents alcalinisants ou acidifiants, des conservateurs et des antioxydants.The article may also contain any ingredients commonly used in cosmetics or dermatology and physiologically acceptable, such as for example fillers, thickeners, surfactants, trace elements, sequestering agents, perfumes, alkalizing or acidifying agents, preservatives and antioxidants.
L'article peut comporter par exemple au moins un composé destiné à permettre la formation de mousse lorsque l'article est mis au contact d'eau en présence d'une agitation, par exemple au moins un tensio-actif anionique, cationique ou amphotère ou non ionique. Comme tensioactifs de ce type, on peut citer par exemple :
- (1) parmi les tensioactifs non ioniques, les polymères blocs oxyéthylénés oxypropylénés tels que le Poloxamer 184 (nom CTFA) ; les alkylpolyglycosides et notamment les alkylpolyglucosides (APG) ayant un groupe alkyle comportant de 6 à 30 atomes de carbone (alkyl-C6-C30 polyglucosides) et de préférence 8 à 16 atomes de carbone, comme par exemple le decylglucoside (Alkyl-C9/C11-polyglucoside (1.4) tel que le produit commercialisé sous la dénomination MYDOL 10 par la société Kao Chemicals, le produit commercialisé sous la dénomination PLANTAREN 2000 UP ou PLANTACARE 2000 UP par la société Henkel, et le produit commercialisé sous la dénomination
ORAMIX NS 10 par la société Seppic ; le caprylyl/capryl glucoside comme le produit commercialisé sous la dénomination ORAMIX CG 110 par la Société Seppic ; le laurylglucoside comme les produits commercialisés sous les dénominations PLANTAREN 1200 N et PLANTACARE 1200 par la société Henkel ; et le coco-glucoside comme le produit commercialisé sous la dénomination PLANTACARE 818/UP par la société Henkel ; - (2) parmi les tensioactifs anioniques, les alkylsulfates, les alkyl éther sulfates et leurs sels, notamment leurs sels de sodium, comme le mélange de Sodium Laureth Sulfate / Magnesium Laureth Sulfate / Sodium Laureth-8 Sulfate / Magnesium Laureth-8 Sulfate, vendu sous le nom de Texapon ASV par la société Henkel ; le lauryl éther sulfate de sodium (C12-14 70/30) (2,2 OE) commercialisé sous les dénominations SIPON AOS 225 ou TEXAPON N702 PATE par la société Henkel, le lauryl éther sulfate d'ammonium (C12-14 70/30) (3 OE) commercialisé sous la dénomination SIPON LEA 370 par la société Henkel ; l'alkyl (C12-C14) éther (9 OE) sulfate d'ammonium commercialisé sous la dénomination RHODAPEX AB/20 par la société Rhodia Chimie ;
- (3) parmi les tensioactifs amphotères ou zwitterioniques, les dérivés alkylamido alkylamines tels que le N-cocoyl-N-carboxyméthoxyéthyl-N-carboxyméthyléthylènediamine N-di-sodique (nom CTFA : Disodium cocoampho-diacetate) commercialisé en solution aqueuse saline sous la dénomination MIRANOL C2M CONC NP par la société Rhodia Chimie ; le N-cocoyl-N-hydroxyéthyl-N-carboxyméthyléthylènediamine N-sodique (nom CTFA : sodium cocampho-acetate) et le mélange d'éthanolamides d'acide de coco (nom CTFA : Cocamide DEA).
- (1) among the nonionic surfactants, oxyethylenated oxypropylene block polymers such as Poloxamer 184 (CTFA name); alkylpolyglycosides and especially alkylpolyglucosides (APG) having an alkyl group containing from 6 to 30 carbon atoms (alkyl-C 6 -C 30 polyglucosides) and preferably 8 to 16 carbon atoms, for example decylglucoside (C9-Alkyl) / C11-polyglucoside (1.4), such as the product marketed under the name MYDOL 10 by the company Kao Chemicals, the product marketed under the name PLANTAREN 2000 UP or PLANTACARE 2000 UP by Henkel, and the product marketed under the
name ORAMIX NS 10 by the company Seppic, caprylyl / capryl glucoside, such as the product sold under the name ORAMIX CG 110 by the company Seppic, laurylglucoside, and the products sold under the names Plantaren 1200 N and Plantacare 1200 by Henkel; glucoside, such as the product marketed under the name PLANTACARE 818 / UP by Henkel; - (2) among the anionic surfactants, the alkyl sulphates, the alkyl ether sulphates and their salts, especially their sodium salts, such as the mixture of Sodium Laureth Sulfate / Magnesium Laureth Sulfate / Sodium Laureth-8 Sulfate / Magnesium Laureth-8 Sulfate, sold under the name Texapon ASV by Henkel; sodium lauryl ether sulphate (C12-14 70/30) (2.2 EO) sold under the names SIPON AOS 225 or TEXAPON N702 PATE by Henkel, ammonium lauryl ether sulphate (C12-14 70/30). ) (3 EO) marketed under the name SIPON LEA 370 by Henkel; the alkyl (C12-C14) ether (9 EO) ammonium sulphate sold under the name RHODAPEX AB / 20 by the company Rhodia Chimie;
- (3) from amphoteric or zwitterionic surfactants, alkylamido alkylamine derivatives such as N-cocoyl-N-carboxymethoxyethyl-N-carboxymethylethylenediamine N-di-sodium (CTFA name: Disodium cocoampho-diacetate) marketed in aqueous saline solution under the name MIRANOL C2M CONC NP by Rhodia Chimie; N-cocoyl-N-hydroxyethyl-N-carboxymethylethylenediamine N-sodium (CTFA name: sodium cocampho-acetate) and the mixture of coconut acid ethanolamides (CTFA name: Cocamide DEA).
L'article peut comprendre aussi un mélange de ces tensioactifs.The article may also include a mixture of these surfactants.
L'article peut comporter des composés destinés à réagir ensemble en présence d'eau, par exemple pour provoquer une effervescence, par exemple au moins un acide organique, notamment l'acide citrique, et au moins un agent alcalin, par exemple le bicarbonate de soude.The article may comprise compounds intended to react together in the presence of water, for example to cause effervescence, for example at least one organic acid, in particular citric acid, and at least one alkaline agent, for example sodium bicarbonate. welded.
Au moins un composé cosmétique ou dermatologique et plus généralement la composition cosmétique ou dermatologique peut être présente ou non à l'extérieur de l'article.At least one cosmetic or dermatological compound and more generally the cosmetic or dermatological composition may or may not be present outside the article.
Lorsque la composition est présente à l'extérieur de l'article, ce dernier peut être utilisé par exemple en étant amené au contact de la région à traiter, de manière à permettre à la composition de transférer. Ce transfert peut s'effectuer, le cas échéant, en frottant l'article sur la région à traiter.When the composition is present outside the article, the latter can be used for example by being brought into contact with the region to be treated, so as to allow the composition to transfer. This transfer can be made, if necessary, by rubbing the article on the region to be treated.
Dans le cas où la composition est présente à l'extérieur de l'article, ce dernier peut ne pas être mouillé lors de l'utilisation, la solubilisation du support n'ayant lieu qu'après l'utilisation.In the case where the composition is present on the outside of the article, the latter may not be wet during use, the solubilization of the support taking place after use.
Lorsque la composition est présente à l'extérieur du support, l'article peut néanmoins dans certains cas être mouillé lors de l'utilisation, par exemple pour modifier des propriétés de la composition, améliorer le transfert de la composition ou former un produit filmogène.When the composition is present outside the support, the article may nevertheless in certain cases be wet during use, for example to modify properties of the composition, improve the transfer of the composition or form a film-forming product.
Lorsque la composition n'est pas présente à l'extérieur de l'article, le support peut avoir à être solubilisé au moins partiellement, voire entièrement, avant l'utilisation.When the composition is not present outside the article, the support may have to be solubilized at least partially or completely before use.
La composition peut être présente dans l'article au moins partiellement, voire totalement, sous une forme pulvérulente, notamment une forme pulvérulente sensiblement anhydre. L'article peut, par exemple, être sec au toucher. La granulométrie de la composition pourra être choisie en fonction de la porosité du support de façon à diminuer les pertes au secouage.The composition may be present in the article at least partially, or totally, in a pulverulent form, in particular a substantially anhydrous pulverulent form. The article may, for example, be dry to the touch. The particle size of the composition may be chosen according to the porosity of the support so as to reduce the shaking losses.
La composition, lorsqu'elle est pulvérulente, peut être contenue dans une cavité du support, par exemple formée entre deux couches de celui-ci comme c'est le cas de l'exemple de réalisation de la figure 2, ou être dispersée, par exemple de manière homogène, au sein du support, notamment au sein d'une couche fibreuse unique du support comme c'est le cas de l'exemple de réalisation de la figure 4.The composition, when it is pulverulent, may be contained in a cavity of the support, for example formed between two layers thereof, as is the case of the embodiment of FIG. 2, or dispersed by homogeneously example, within the support, in particular within a single fibrous layer of the support as is the case of the embodiment of Figure 4.
La composition peut ne pas être pulvérulente mais être liquide, crémeuse ou pâteuse, formant par exemple une pâte. Dans ce cas, la composition comporte par exemple un ou plusieurs solvants compatibles avec la nature du support, notamment des solvants non aqueux, de façon à éviter sa dissolution prématurée, comme par exemple les alcools inférieurs comportant de 1 à 6 atomes de carbone, tels que l'éthanol ; les polyols tels que la glycérine ; les glycols comme le butylène glycol, l'isoprène glycol, l'hexylène glycol, le propylène glycol ; les polyéthylène glycols tels que le PEG-8, le sorbitol ; les huiles hydrocarbonées d'origine animale, telles que le perhydrosqualène; les huiles hydrocarbonées d'origine végétale, telles que les glycérides mono- ou di- ou tri- esters d'acides gras et de glycérol, par exemple les huiles d'amande douce, de tournesol, de maïs, de soja, de noisette, d'abricot ; les triglycérides d'origine synthétique comme ceux vendus par la société Stearineries Dubois ou ceux vendus sous les dénominations Miglyol 810, 812 et 818 par la société Dynamit Nobel ; les esters et les éthers de synthèse, notamment d'acides gras, comme les huiles de formules R1COOR2 et R1OR2 dans laquelle R1 représente le reste d'un acide gras comportant de 8 à 29 atomes de carbone, et R2 représente une chaîne hydrocarbonée, ramifiée ou non, contenant de 3 à 30 atomes de carbone, comme par exemple l'huile de Purcellin, l'isononanoate d'isononyle, le stéarate d'octyl-2-dodécyle, l'isostéaryl lactate, l'octylhydroxystéarate, le citrate de triisocétyle ; les esters de polyol, comme le dioctanoate de propylène glycol, le diisononanoate de diéthylèneglycol ; et les esters du pentaérythritol ; les hydrocarbures linéaires ou ramifiés, d'origine minérale ou synthétique, tels que les huiles de paraffine, volatiles ou non ; les alcools gras ayant de 8 à 26 atomes de carbone, comme l'alcool cétylique, l'alcool stéarylique et leur mélange (alcool cétéarylique), l'octyldodécanol, le 2-hexyldécanol ; les alcools gras alcoxylés et notamment éthoxylés tels que l'oleth-12 ou le ceteareth-20 ; les huiles fluorées partiellement hydrocarbonées et/ou siliconées comme celles décrites dans le document JP-A-2-295912. Comme huiles fluorées, on peut citer aussi le perfluorométhylcyclopentane et le perfluoro-1,3 diméthylcyclohexane, vendus sous les dénominations de "FLUTEC PC1®" et "FLUTEC PC3®" par la Société BNFL Fluorochemicals ; les perfluoroalcanes tels que le dodécafluoropentane et le tétradécafluorohexane, vendus sous les dénominations de "PF 5050®" et "PF 5060®" par la Société 3M ; les huiles de silicone comme les polyméthylsiloxanes (PDMS) volatiles ou non à chaîne siliconée linéaire ou cyclique, liquides ou pâteux à température ambiante, notamment les cyclopolydiméthylsiloxanes (cyclométhicones) telles que la cyclohexasiloxane ; les polydiméthylsiloxanes comportant des groupements alkyle, alcoxy ou phényle, pendant ou en bout de chaîne siliconée, groupements ayant de 2 à 24 atomes de carbone ; les silicones phénylées comme les phényltriméthicones, les phényldiméthicones, les phényltriméthylsiloxydiphényl-siloxanes, les diphényldiméthicones, les diphénylméthyldiphényl trisiloxanes, les 2-phényléthyltriméthylsiloxysilicates, et les polyméthylphénylsiloxanes.The composition may not be pulverulent but may be liquid, creamy or pasty, forming for example a paste. In this case, the composition comprises, for example, one or more solvents compatible with the nature of the support, in particular non-aqueous solvents, so as to avoid premature dissolution, such as, for example, lower alcohols containing from 1 to 6 carbon atoms, such as ethanol; polyols such as glycerine; glycols such as butylene glycol, isoprene glycol, hexylene glycol, propylene glycol; polyethylene glycols such as PEG-8, sorbitol; hydrocarbon oils of animal origin, such as perhydrosqualene; hydrocarbon oils of vegetable origin, such as glycerides mono- or di- or tri-esters of fatty acids and of glycerol, for example sweet almond, sunflower, corn, soybean or hazelnut oils, apricot; triglycerides of synthetic origin, such as those sold by Stearineries Dubois or those sold under the names Miglyol 810, 812 and 818 by Dynamit Nobel; esters and synthetic ethers, in particular of fatty acids, such as the oils of formulas R 1 COOR 2 and R 1 OR 2 in which R 1 represents the residue of a fatty acid having from 8 to 29 carbon atoms, and R 2 represents a hydrocarbon chain, branched or no, containing from 3 to 30 carbon atoms, such as, for example, purcellin oil, isononyl isononanoate, octyl-2-dodecyl stearate, isostearyl lactate, octylhydroxystearate, triisocetyl citrate ; polyol esters, such as propylene glycol dioctanoate, diethylene glycol diisononanoate; and pentaerythritol esters; linear or branched hydrocarbons of mineral or synthetic origin, such as paraffin oils, volatile or not; fatty alcohols having 8 to 26 carbon atoms, such as cetyl alcohol, stearyl alcohol and their mixture (cetearyl alcohol), octyldodecanol, 2-hexyldecanol; alkoxylated and especially ethoxylated fatty alcohols such as oleth-12 or ceteareth-20; partially hydrocarbon and / or silicone fluorinated oils such as those described in document JP-A-2-295912. As fluorinated oils, mention may also be made of perfluoromethylcyclopentane and perfluoro-1,3-dimethylcyclohexane, sold under the names "FLUTEC PC1®" and "FLUTEC PC3®" by BNFL Fluorochemicals; perfluoroalkanes such as dodecafluoropentane and tetradecafluorohexane sold under the names "PF 5050®" and "PF 5060®" by the company 3M; silicone oils such as volatile or non-volatile polymethylsiloxanes (PDMS) with a linear or cyclic silicone chain, which are liquid or pasty at room temperature, in particular cyclopolydimethylsiloxanes (cyclomethicones) such as cyclohexasiloxane; polydimethylsiloxanes comprising alkyl, alkoxy or phenyl groups, during or at the end of the silicone chain, groups having from 2 to 24 carbon atoms; phenyl silicones such as phenyltrimethicones, phenyldimethicones, phenyltrimethylsiloxydiphenylsiloxanes, diphenyldimethicones, diphenylmethyldiphenyltrisiloxanes, 2-phenylethyltrimethylsiloxysilicates, and polymethylphenylsiloxanes.
On entend par "huile hydrocarbonée" dans la liste des huiles citées ci-dessus, toute huile comportant majoritairement des atomes de carbone et d'hydrogène, et éventuellement des groupements ester, éther, fluoré, acide carboxylique et/ou alcool.The term "hydrocarbon-based oil" in the list of oils mentioned above, any oil predominantly comprising carbon and hydrogen atoms, and optionally ester, ether, fluoro, carboxylic acid and / or alcohol groups.
La composition pourra contenir une certaine quantité d'eau au moment de son imprégnation sur le support. De manière à éviter sa solubilisation prématurée, l'eau introduite sur le support lors de son imprégnation sera éliminée par les moyens classiquement utilisés pour la déshydratation des compositions contenant de l'eau, comme par exemple le chauffage.The composition may contain a certain amount of water at the time of its impregnation on the support. In order to avoid its premature solubilization, the water introduced on the support during its impregnation will be eliminated by the means conventionally used for the dehydration of compositions containing water, such as heating.
La composition peut être déposée sur une face seulement du support, l'autre face du support pouvant être utilisée par exemple pour la préhension de l'article.The composition can be deposited on one side only of the support, the other side of the support can be used for example for gripping the article.
Dans le cas d'une composition colorée, l'article est conditionné par exemple dans un emballage tel qu'une boîte 30, comme illustré à la figure 11. Un témoin 31 indicatif de la couleur du produit obtenu après dissolution du support peut figurer sur l'emballage, le cas échéant, pour renseigner le consommateur avant l'achat.In the case of a colored composition, the article is packaged for example in a package such as a
Lorsque la composition est incorporée durant la fabrication de l'article dans celui-ci, l'article est par exemple conditionné en vrac dans une boîte ou dans un emballage individuel. Le cas échéant, les articles sont conditionnés en chapelet. Les articles peuvent encore être repliés sur eux-mêmes et intercalés, de telle sorte que le retrait d'un article amène le suivant dans une configuration facilitant sa préhension.When the composition is incorporated during the manufacture of the article therein, the article is for example packaged in bulk in a box or in an individual package. In this case, the articles are packed in a rosary. The articles can still be folded on themselves and interposed, so that the removal of an article brings the next in a configuration facilitating its grip.
Lorsque la composition doit être déposée sur le support par l'utilisateur lui-même, la composition et le support peuvent être proposés sous la forme d'un kit, par exemple. La composition est par exemple livrée en une quantité suffisante pour permettre d'en distribuer une pluralité de doses sur un ensemble de supports destinés à être utilisés successivement.When the composition is to be deposited on the support by the user himself, the composition and the support may be provided in the form of a kit, for example. The composition is for example delivered in an amount sufficient to allow to distribute a plurality of doses on a set of media to be used successively.
Exemple A : Maquillage de la peau, notamment des paupières On réalise un support en découpant une forme ovoïde d'environ 5 cm de long et 1,5 cm de large à partir d'une nappe de KURALON K-II WN2 d'épaisseur environ 0,5mm et de grammage 60 g/m2. EXAMPLE A Makeup of the Skin, in particular the Eyelids A support is made by cutting an ovoid shape approximately 5 cm long and 1.5 cm wide from a KURALON K-II WN2 sheet approximately of thickness 0.5mm and weight 60 g / m 2 .
Selon l'intensité du maquillage recherché ce support est imprégné par une quantité comprise entre 0,02 g et 0,1 g de la composition pulvérulente colorée suivante, déposée sur une face de celui-ci.
Le support ainsi imprégné est doux au toucher et de préhension facile notamment par sa face opposée à celle portant la composition et peut être déplacé sur la peau de manière à permettre à la composition de transférer sur celle-ci.The support thus impregnated is soft to the touch and easy to grip especially by its opposite side to that bearing the composition and can be moved on the skin so as to allow the composition to transfer on it.
Après utilisation, le support est facilement éliminé sous l'eau courante.After use, the support is easily removed under running water.
L'imprégnation du support peut s'effectuer au moment de l'utilisation ou le support peut être proposé à l'utilisateur pré-imprégné, dans un emballage individuel notamment.The impregnation of the support can be carried out at the time of use or the support can be offered to the pre-impregnated user, in particular individual packaging.
On réalise un support en découpant une forme ronde d'environ 5 cm de diamètre dans une nappe de KURALON K-II WN2 d'épaisseur environ 2mm et de grammage 80 g/m2.A support is made by cutting a round shape about 5 cm in diameter in a sheet of KURALON K-II WN2 thickness of about 2mm and 80 g / m 2 basis weight.
Ce support est imprégné de 0,1g de la composition pulvérulente suivante, déposée sur une face de celui-ci.
Après utilisation, le support est facilement éliminé sous l'eau courante.After use, the support is easily removed under running water.
Le même support qu'à l'exemple A est enduit avec 0,25g de la composition de blush pâteuse anhydre suivante :
Après utilisation, le support est facilement éliminé par dissolution dans l'eau froide.After use, the support is easily removed by dissolution in cold water.
Un article tel que celui illustré aux figures 1 et 2 est réalisé avec des fibres KURALON K-II WN2 en thermosoudant à leur périphérie les couches 2 et 3, et en ayant préalablement introduit la composition cosmétique dans la cavité 4. Les couches 2 et 3 ont un grammage compris entre 70 et 80 g/m2 et une épaisseur comprise entre 3 et 4 mm. L'article se présente sous la forme d'un disque de 3cm de diamètre contenant environ 0,3g d'une composition colorée pulvérulente ayant la formulation suivante :
Pour utiliser l'article, on dispose celui-ci dans le creux de la main et l'on verse de l'eau sur le support.To use the article, it is placed in the palm of the hand and water is poured on the support.
Les fibres de PVA contribuent à texturer la composition et/ou lui confèrent des propriétés filmogènes. L'utilisateur peut agir sur la texture du produit en ajoutant plus ou moins d'eau.The PVA fibers contribute to texture the composition and / or give it film-forming properties. The user can act on the texture of the product by adding more or less water.
Le produit ainsi formé peut être étalé sur le corps ou le visage directement avec les doigts ou en utilisant un applicateur, par exemple un embout floqué, comme une mousse, un feutre, du coton ou un pinceau.The product thus formed can be spread on the body or face directly with the fingers or by using an applicator, for example a flocked tip, such as a foam, a felt, cotton or a brush.
On réalise un article comportant un support constitué par un disque de 7 cm de diamètre d'une nappe de fibres de KURALON K-II WN2 de grammage 80 g/m2 et de 2 mm d'épaisseur, imprégné de 0,2 g d'une composition déodorante pulvérulente ayant la formulation suivante :
L'article s'utilise à sec, en essuyant les aisselles.The item is used dry, wiping underarms.
L'affinité pour l'eau du support permet d'essuyer d'éventuels résidus de transpiration.The affinity for the water of the support makes it possible to wipe off any residues of perspiration.
Un article tel que celui illustré aux figures 1 et 2 est réalisé avec des fibres KURALON K-II WN2 en thermosoudant à leur périphérie les couches 2 et 3, et en ayant préalablement introduit la composition cosmétique dans la cavité 4. L'article se présente sous la forme d'un disque de 3cm de diamètre L'article contient environ 0,3g d'une composition de nettoyage pulvérulente ayant la formulation suivante :
Pour utiliser l'article, on dispose celui-ci dans le creux de la main et l'on verse à peu près 3cm3 d'eau dessus.To use the article, it is placed in the palm of the hand and poured about 3cm 3 of water on it.
On remue celui-ci avec l'index de l'autre main en rajoutant jusqu'à 3 à 6 cm3 d'eau si nécessaire, de manière à obtenir une mousse homogène après solubilisation complète du support.This is stirred with the index finger of the other hand by adding up to 3 to 6 cm 3 of water if necessary, so as to obtain a homogeneous foam after complete solubilization of the support.
Cette mousse peut être utilisée pour se laver les mains ou le visage, par exemple.This foam can be used to wash your hands or face, for example.
On réalise une lingette de la manière suivante.A wipe is made in the following manner.
On découpe une nappe de 10 cm de côté de grammage 60 g/m2 et d'épaisseur 1 mm en KURALON K-II WN2 que l'on imprègne de 0,9 g de la composition moussante concentrée suivante :
Cette composition contient au moins 15 % d'eau. Elle se présente sous la forme d'une pâte que l'on dépose sur le support par les moyens classiques, comme l'enduction par exemple.This composition contains at least 15% water. It is in the form of a paste that is deposited on the support by conventional means, such as coating for example.
On fait sécher la composition, et celle-ci adhère aux fibres une fois sèche.The composition is dried, and the composition adheres to the fibers once dry.
Une fois sec, le support est calandré entre des rouleaux, pour le densifier, le rigidifier et diminuer la porosité en surface.Once dry, the support is calendered between rollers, to densify, stiffen and reduce surface porosity.
Pour utiliser l'article, la lingette est passée sous l'eau puis frictionnée pour créer la mousse et solubiliser le support.To use the article, the wipe is passed under water and then rubbed to create the foam and solubilize the support.
On réalise un article destiné au rasage avec le même support que celui de l'exempleE, la composition de l'exemple précédent étant remplacée par la suivante :
Cette composition contient au moins 15 % d'eau. Elle se présente sous la forme d'une pâte que l'on dépose sur le support par les moyens classiques comme l'enduction par exemple.This composition contains at least 15% water. It is in the form of a paste that is deposited on the support by conventional means such as coating for example.
On fait sécher la composition, et celle-ci adhère aux fibres une fois sèche.The composition is dried, and the composition adheres to the fibers once dry.
Une fois sec, le support est calandré entre des rouleaux, pour le densifier, le rigidifier et diminuer la porosité en surface.Once dry, the support is calendered between rollers, to densify, stiffen and reduce surface porosity.
Pour utiliser l'article, celui-ci est appliqué sur les joues préalablement humectées, puis on frictionne en rajoutant graduellement de l'eau.To use the article, it is applied to the cheeks previously moistened, then rubs by gradually adding water.
On réalise une compresse démaquillante destinée au démaquillage du visage avec le même support que celui de l'exemple E, la composition de l'exemple précédent étant remplacée par la suivante :
La composition est anhydre, elle est imprégnée sur le support par des moyens classiques comme par exemple des rouleaux lécheurs ou des rampes d'imprégnation.The composition is anhydrous, it is impregnated on the support by conventional means such as for example lick rollers or impregnation ramps.
Une émulsion démaquillante est générée en passant la feuille sur le visage mouillé ou mieux en la frottant dans le creux de la main avec un peu d'eau.A cleansing emulsion is generated by passing the leaf on the wet face or better by rubbing it in the palm of the hand with a little water.
Bien entendu, l'invention n'est pas limitée aux exemples qui viennent d'être décrits.Of course, the invention is not limited to the examples which have just been described.
On peut notamment utiliser d'autres actifs que ceux mentionnés ci-dessus.In particular, it is possible to use other assets than those mentioned above.
Dans toute la description, y compris les revendications, les proportions sont massiques, sauf si le contraire est spécifié.Throughout the description, including the claims, the proportions are by weight, unless the opposite is specified.
L'expression « comportant un » doit se comprendre comme étant synonyme de « comportant au moins un », sauf si le contraire est spécifié.The expression "comprising one" must be understood as being synonymous with "having at least one" unless the contrary is specified.
L'expression « compris entre » doit se comprendre bornes incluses.The expression "included between" must be understood inclusive terms.
Claims (37)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0550014A FR2880262B1 (en) | 2005-01-03 | 2005-01-03 | COSMETIC OR DERMATOLOGICAL ARTICLE COMPRISING A WATER-SOLUBLE SUPPORT |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1676559A2 true EP1676559A2 (en) | 2006-07-05 |
EP1676559A3 EP1676559A3 (en) | 2006-09-13 |
EP1676559B1 EP1676559B1 (en) | 2016-04-27 |
Family
ID=35432577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP05301104.5A Active EP1676559B1 (en) | 2005-01-03 | 2005-12-23 | Cosmetic or dermatological article containing a support which is soluble in water |
Country Status (5)
Country | Link |
---|---|
US (1) | US20110033509A1 (en) |
EP (1) | EP1676559B1 (en) |
JP (2) | JP4316564B2 (en) |
ES (1) | ES2581956T3 (en) |
FR (1) | FR2880262B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2897262A1 (en) * | 2006-02-14 | 2007-08-17 | Oreal | Single-use cosmetic article e.g. wipe for removing makeup comprises polyvinyl alcohol fiber derived water-soluble nonwoven substrate; and anhydrous cosmetic composition containing oil and nonionic emulsifying surfactant soluble in the oil |
CN102764478A (en) * | 2011-05-04 | 2012-11-07 | 抛罗根有限公司 | Apparatus and method for using effervescent tablets for cosmetic care |
WO2014095378A1 (en) * | 2012-12-18 | 2014-06-26 | Gunnar Myhre | Shaving foam wipe unit |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2880262B1 (en) * | 2005-01-03 | 2013-11-08 | Oreal | COSMETIC OR DERMATOLOGICAL ARTICLE COMPRISING A WATER-SOLUBLE SUPPORT |
ZA200804693B (en) * | 2007-05-30 | 2009-02-25 | Oreal | Cosmetic hair compositions containing metal-oxide layered pigments and functionalized metal-oxide layered pigments and methods of use |
KR200462101Y1 (en) | 2009-09-23 | 2012-08-28 | 백연화 | Disposable hair mask pack |
BR112013000101A2 (en) | 2010-07-02 | 2016-05-17 | Procter & Gamble | filaments comprising active agent nonwoven webs and methods of manufacture thereof |
EP2588654B1 (en) * | 2010-07-02 | 2019-08-07 | The Procter and Gamble Company | Nonwoven web comprising one or more active agents |
WO2012143013A1 (en) * | 2011-04-18 | 2012-10-26 | Rigshospitalet Copenhagen University Hospital | Improved wound care product |
FR3015231B1 (en) | 2013-12-23 | 2017-02-24 | Oreal | PACKAGING ARTICLE COMPRISING AN ENVELOPE ANHYDROUS COLORING COMPOSITION COMPRISING A DIRECT COLOR, USE AND METHOD FOR COLORING KERATINIC FIBERS |
FR3015232B1 (en) * | 2013-12-23 | 2016-01-08 | Oreal | PACKAGING ARTICLE COMPRISING AN ENVELOPE ANHYDROUS COLORING COMPOSITION COMPRISING AN OXIDATION COLOR, USE AND METHOD FOR COLORING KERATIN FIBERS |
FR3016288B1 (en) | 2013-12-23 | 2016-09-09 | Oreal | PACKAGING ARTICLE COMPRISING AN ENVELOPE AND ANHYDROUS COMPOSITION COMPRISING AN OXIDIZING AGENT |
CN114796017A (en) | 2014-04-22 | 2022-07-29 | 宝洁公司 | Composition in the form of a soluble solid structure |
US10773405B2 (en) * | 2016-06-30 | 2020-09-15 | The Gillette Company Llc | Shaving aid for razor cartridges comprising a nano-filament comprising a core and sheath |
EP4245296A3 (en) | 2017-01-27 | 2023-12-06 | The Procter & Gamble Company | Compositions in the form of dissolvable solid structures |
US11697904B2 (en) | 2017-01-27 | 2023-07-11 | The Procter & Gamble Company | Active agent-containing articles that exhibit consumer acceptable article in-use properties |
US11697906B2 (en) * | 2017-01-27 | 2023-07-11 | The Procter & Gamble Company | Active agent-containing articles and product-shipping assemblies for containing the same |
JP6886045B2 (en) * | 2017-01-27 | 2021-06-16 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | Activator-containing articles that exhibit consumer-acceptable article usage characteristics |
US11697905B2 (en) | 2017-01-27 | 2023-07-11 | The Procter & Gamble Company | Active agent-containing articles that exhibit consumer acceptable article in-use properties |
EP3624765A1 (en) | 2017-05-16 | 2020-03-25 | The Procter and Gamble Company | Conditioning hair care compositions in the form of dissolvable solid structures |
JP1639110S (en) | 2018-07-16 | 2019-08-13 | ||
US11666514B2 (en) | 2018-09-21 | 2023-06-06 | The Procter & Gamble Company | Fibrous structures containing polymer matrix particles with perfume ingredients |
CN114173749A (en) | 2019-06-28 | 2022-03-11 | 宝洁公司 | Water soluble personal cleansing products and uses |
BR112021023244A2 (en) | 2019-06-28 | 2022-01-04 | Procter & Gamble | Soluble solid fibrous articles containing anionic surfactants |
MX2021015391A (en) | 2019-07-03 | 2022-01-24 | Procter & Gamble | Fibrous structures containing cationic surfactants and soluble acids. |
JP7381710B2 (en) * | 2019-07-31 | 2023-11-15 | ザ プロクター アンド ギャンブル カンパニー | Water-soluble personal cleansing products, uses, methods and kits containing fiber elements containing natural or modified starches |
US10945929B2 (en) * | 2019-08-05 | 2021-03-16 | L'oreal | Anhydrous compositions and articles for makeup removal |
USD939359S1 (en) | 2019-10-01 | 2021-12-28 | The Procter And Gamble Plaza | Packaging for a single dose personal care product |
EP4045425B1 (en) | 2019-10-14 | 2024-03-06 | The Procter & Gamble Company | Biodegradable and/or home compostable sachet containing a solid article |
CA3157576A1 (en) | 2019-11-20 | 2021-05-27 | The Procter & Gamble Company | Porous dissolvable solid structure |
WO2021113211A1 (en) | 2019-12-01 | 2021-06-10 | The Procter & Gamble Company | Hair conditioner compositions with a preservation system containing sodium benzoate and glycols and/or glyceryl esters |
USD962050S1 (en) | 2020-03-20 | 2022-08-30 | The Procter And Gamble Company | Primary package for a solid, single dose beauty care composition |
USD941051S1 (en) | 2020-03-20 | 2022-01-18 | The Procter And Gamble Company | Shower hanger |
USD965440S1 (en) | 2020-06-29 | 2022-10-04 | The Procter And Gamble Company | Package |
EP4188554A1 (en) | 2020-07-31 | 2023-06-07 | The Procter & Gamble Company | Water-soluble fibrous pouch containing prills for hair care |
WO2022036352A1 (en) | 2020-08-11 | 2022-02-17 | The Procter & Gamble Company | Clean rinse hair conditioner compositions containing brassicyl valinate esylate |
US11633338B2 (en) | 2020-08-11 | 2023-04-25 | The Procter & Gamble Company | Moisturizing hair conditioner compositions containing brassicyl valinate esylate |
CN116456957A (en) | 2020-08-11 | 2023-07-18 | 宝洁公司 | Low viscosity hair conditioner compositions containing valine ester ethane sulfonate of brassinolide |
JP2023553395A (en) | 2020-12-01 | 2023-12-21 | ザ プロクター アンド ギャンブル カンパニー | Aqueous hair conditioner compositions containing solubilized anti-dandruff actives |
WO2023199243A1 (en) * | 2022-04-13 | 2023-10-19 | Health And Earth Care Solutions (Pty) Ltd | Water-soluble wet wipes |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3803300A (en) * | 1970-03-18 | 1974-04-09 | H Pospischil | Ointment foil and method of preparing the same |
EP0653635A1 (en) * | 1993-11-17 | 1995-05-17 | Srl, Inc. | Physiologically active substance fixed sheet, process for its production, method for its storage, and method of supplying physiologically active substance through the sheet |
WO1996025910A1 (en) * | 1995-02-23 | 1996-08-29 | Cygnus, Inc. | Water-soluble pressure-sensitive mucoadhesive |
US5567431A (en) * | 1991-03-14 | 1996-10-22 | Centre National De La Recherche Scientifique (Cnrs) | Polylactic acid-based implant susceptible of bioresorption containing and antibiotic |
GB2302651A (en) * | 1995-03-22 | 1997-01-29 | Teikoku Seiyaku Kk | Cold sheet |
US5629003A (en) * | 1990-06-07 | 1997-05-13 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Rapidly disintegrating sheet-like presentations of multiple dosage units |
WO2000030578A1 (en) * | 1998-11-23 | 2000-06-02 | Bio-Silk Ltd. | Enzymatic treatment and prevention of hypertrophic skin |
US6175054B1 (en) * | 1995-11-01 | 2001-01-16 | Bristol-Myers Squibb Company | Water soluble films |
WO2002017853A2 (en) * | 2000-08-31 | 2002-03-07 | Genzyme Biosurgery Corporation | Hyaluronan-based antiadhesion compositions, their preparation and use |
WO2003037282A1 (en) * | 2001-11-01 | 2003-05-08 | The Procter & Gamble Company | Method of using personal care compositions containing a high density, water disintegratable, polymeric foam |
US20030099692A1 (en) * | 2001-11-16 | 2003-05-29 | Susan Lydzinski | Film containing starch |
WO2004032859A2 (en) * | 2002-10-09 | 2004-04-22 | The Dial Corporation | Water soluble sheet composition |
WO2004052347A1 (en) * | 2002-12-05 | 2004-06-24 | Lts Lohmann Therapie-Systeme Ag | Transmucosal and transdermal medicaments with an improved active ingredient absorption |
US20040137041A1 (en) * | 2003-01-09 | 2004-07-15 | Jakwang Co., Ltd. | Water-soluble natural film and its preparing method |
EP1454950A1 (en) * | 2001-07-19 | 2004-09-08 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Pullulan-containing powder, process for producing the same and use thereof |
US20040247649A1 (en) * | 2002-02-11 | 2004-12-09 | Edizone, Lc | Medicine-containing orally soluble films |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4303543A (en) * | 1979-02-27 | 1981-12-01 | The Procter & Gamble Company | Method for cleansing and conditioning the skin |
JPH0653657B2 (en) * | 1985-09-26 | 1994-07-20 | サンスタ−株式会社 | Bath agent |
JPH02279800A (en) * | 1989-04-20 | 1990-11-15 | Dai Ichi Kogyo Seiyaku Co Ltd | Film-like or sheet-like soap |
US5181966A (en) * | 1991-04-10 | 1993-01-26 | Honeycutt Travis W | Hot water soluble packaging materials |
US5256417A (en) * | 1992-01-31 | 1993-10-26 | Air Products And Chemicals, Inc. | Water dispersible towelette impregnated with non-aqueous lotion formulations |
DE69625549T2 (en) * | 1995-06-27 | 2003-05-15 | Kao Corp | Plaster with a water-soluble adhesive layer |
JP3474981B2 (en) * | 1995-10-11 | 2003-12-08 | 花王株式会社 | Bath agent |
JP3595057B2 (en) * | 1996-02-09 | 2004-12-02 | 花王株式会社 | Sheet-shaped cosmetic composition |
JPH10183200A (en) * | 1996-10-24 | 1998-07-14 | Dainippon Jochugiku Co Ltd | Germicidal detergent |
JP3398313B2 (en) * | 1997-10-24 | 2003-04-21 | 花王株式会社 | Sheet laundry products |
JP2000072669A (en) * | 1998-08-24 | 2000-03-07 | Inst Of Physical & Chemical Res | Amino acid and sugar composition |
JP2000169896A (en) * | 1998-12-11 | 2000-06-20 | Kao Corp | Article for laundry |
FR2788968B1 (en) * | 1999-01-28 | 2002-06-07 | Oreal | MAKEUP OR CARE COMPOSITION CONTAINING A HYDROPHILIC ORGANOPOLYSILOXANE |
EP1069216A1 (en) * | 1999-07-16 | 2001-01-17 | Kuraray Co., Ltd. | Polyvinyl alcohol based fibers |
JP3640592B2 (en) * | 2000-03-31 | 2005-04-20 | ユニ・チャーム株式会社 | Multi-layered water-decomposable fiber sheet |
US6576575B2 (en) * | 2000-05-15 | 2003-06-10 | Kimberly-Clark Worldwide, Inc. | Dispersible adherent article |
JP2001355170A (en) * | 2000-06-14 | 2001-12-26 | Kuraray Co Ltd | Hydrolyzable dry nonwoven fabric |
GB2366797A (en) * | 2000-09-13 | 2002-03-20 | Procter & Gamble | Process for making foam component by pressurising/depressurising |
FR2819185A1 (en) * | 2001-01-08 | 2002-07-12 | Oreal | COSMETIC COMPOSITION OF PULP TO PULVERULENT TEXTURE AND ITS USE IN COSMETICS |
US20030044366A1 (en) * | 2001-08-10 | 2003-03-06 | Dole Victoria F. | Skin care composition that changes color upon drying |
US6818603B2 (en) * | 2002-08-14 | 2004-11-16 | Johnson & Johnson Consumer Companies, Inc. | Cleansing bar containing discrete elements |
DE10241597B4 (en) * | 2002-09-07 | 2004-09-16 | Scs Skin Care Systems Gmbh | Soap preparation with bubbles |
DE602004025824D1 (en) * | 2003-09-08 | 2010-04-15 | Fmc Biopolymer As | GEL FOAM ON BIOPOLYMER BASE |
FR2880262B1 (en) * | 2005-01-03 | 2013-11-08 | Oreal | COSMETIC OR DERMATOLOGICAL ARTICLE COMPRISING A WATER-SOLUBLE SUPPORT |
-
2005
- 2005-01-03 FR FR0550014A patent/FR2880262B1/en not_active Expired - Fee Related
- 2005-12-23 ES ES05301104.5T patent/ES2581956T3/en active Active
- 2005-12-23 EP EP05301104.5A patent/EP1676559B1/en active Active
- 2005-12-28 JP JP2005381280A patent/JP4316564B2/en active Active
-
2008
- 2008-08-01 JP JP2008199286A patent/JP5331403B2/en active Active
-
2010
- 2010-07-26 US US12/805,327 patent/US20110033509A1/en not_active Abandoned
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3803300A (en) * | 1970-03-18 | 1974-04-09 | H Pospischil | Ointment foil and method of preparing the same |
US5629003A (en) * | 1990-06-07 | 1997-05-13 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Rapidly disintegrating sheet-like presentations of multiple dosage units |
US5567431A (en) * | 1991-03-14 | 1996-10-22 | Centre National De La Recherche Scientifique (Cnrs) | Polylactic acid-based implant susceptible of bioresorption containing and antibiotic |
EP0653635A1 (en) * | 1993-11-17 | 1995-05-17 | Srl, Inc. | Physiologically active substance fixed sheet, process for its production, method for its storage, and method of supplying physiologically active substance through the sheet |
WO1996025910A1 (en) * | 1995-02-23 | 1996-08-29 | Cygnus, Inc. | Water-soluble pressure-sensitive mucoadhesive |
GB2302651A (en) * | 1995-03-22 | 1997-01-29 | Teikoku Seiyaku Kk | Cold sheet |
US6175054B1 (en) * | 1995-11-01 | 2001-01-16 | Bristol-Myers Squibb Company | Water soluble films |
WO2000030578A1 (en) * | 1998-11-23 | 2000-06-02 | Bio-Silk Ltd. | Enzymatic treatment and prevention of hypertrophic skin |
WO2002017853A2 (en) * | 2000-08-31 | 2002-03-07 | Genzyme Biosurgery Corporation | Hyaluronan-based antiadhesion compositions, their preparation and use |
EP1454950A1 (en) * | 2001-07-19 | 2004-09-08 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Pullulan-containing powder, process for producing the same and use thereof |
WO2003037282A1 (en) * | 2001-11-01 | 2003-05-08 | The Procter & Gamble Company | Method of using personal care compositions containing a high density, water disintegratable, polymeric foam |
US20030099692A1 (en) * | 2001-11-16 | 2003-05-29 | Susan Lydzinski | Film containing starch |
US20040247649A1 (en) * | 2002-02-11 | 2004-12-09 | Edizone, Lc | Medicine-containing orally soluble films |
WO2004032859A2 (en) * | 2002-10-09 | 2004-04-22 | The Dial Corporation | Water soluble sheet composition |
WO2004052347A1 (en) * | 2002-12-05 | 2004-06-24 | Lts Lohmann Therapie-Systeme Ag | Transmucosal and transdermal medicaments with an improved active ingredient absorption |
US20040137041A1 (en) * | 2003-01-09 | 2004-07-15 | Jakwang Co., Ltd. | Water-soluble natural film and its preparing method |
Non-Patent Citations (1)
Title |
---|
DATABASE CA CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002358345 extrait de STN Database accession no. 107: 46 074 & JP 62 072609 A (SUNSTAR, INC.) 3 avril 1987 (1987-04-03) * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2897262A1 (en) * | 2006-02-14 | 2007-08-17 | Oreal | Single-use cosmetic article e.g. wipe for removing makeup comprises polyvinyl alcohol fiber derived water-soluble nonwoven substrate; and anhydrous cosmetic composition containing oil and nonionic emulsifying surfactant soluble in the oil |
CN102764478A (en) * | 2011-05-04 | 2012-11-07 | 抛罗根有限公司 | Apparatus and method for using effervescent tablets for cosmetic care |
EP2609830A1 (en) * | 2011-05-04 | 2013-07-03 | Pollogen Ltd | Apparatus and method for using effervescent tablets for cosmetic care |
WO2014095378A1 (en) * | 2012-12-18 | 2014-06-26 | Gunnar Myhre | Shaving foam wipe unit |
Also Published As
Publication number | Publication date |
---|---|
EP1676559A3 (en) | 2006-09-13 |
JP2009007373A (en) | 2009-01-15 |
FR2880262A1 (en) | 2006-07-07 |
JP2006206586A (en) | 2006-08-10 |
JP5331403B2 (en) | 2013-10-30 |
FR2880262B1 (en) | 2013-11-08 |
EP1676559B1 (en) | 2016-04-27 |
JP4316564B2 (en) | 2009-08-19 |
US20110033509A1 (en) | 2011-02-10 |
ES2581956T3 (en) | 2016-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1676559B1 (en) | Cosmetic or dermatological article containing a support which is soluble in water | |
EP1795173B1 (en) | Soluble foaming cosmetic article | |
US20060159730A1 (en) | Cosmetic or dermatological article comprising a medium that is soluble in water | |
EP1637190B1 (en) | Method for shaving using an anhydrous film; use of an anhydrous film for preparing a shaving product; shaving kits | |
US7901696B2 (en) | Cosmetic device comprising discrete elements | |
WO2005074867A1 (en) | Anhydrous film for lip make-up or care | |
EP1405634B1 (en) | Cleansing article and cosmetic use thereof | |
EP2114355A2 (en) | Cosmetic skin care articles and skin care system | |
EP1493433A1 (en) | Porous particles loaded with cosmetical or pharmaceutical active agents | |
FR3004942A1 (en) | CAPILLARY COLORING PROCESS USING HENNE THEN INDIGO AND OIL AND / OR BUTTER | |
EP1795175B1 (en) | Soluble cosmetic article with thermal effect | |
FR2912647A1 (en) | IMPREGNATED WIPE OF A THICK EMULSION. | |
EP1297824A2 (en) | Ultrafine emulsion comprising a haloalkynyl derivative | |
EP1795174A1 (en) | Soluble patch | |
EP2268257A2 (en) | Compositions based on polymer/hydrogen peroxide complexes and uses thereof | |
FR2949058A1 (en) | Cosmetic article useful for removing cosmetics from e.g. skin, contains water-insoluble substrate having layers, and oil-in-water emulsion-type composition comprising thickening polymer of monomer having sulfo group, and inulin | |
FR2897262A1 (en) | Single-use cosmetic article e.g. wipe for removing makeup comprises polyvinyl alcohol fiber derived water-soluble nonwoven substrate; and anhydrous cosmetic composition containing oil and nonionic emulsifying surfactant soluble in the oil | |
FR2894138A1 (en) | Article useful for skin exfoliation comprises a support in the form of sheet comprising fibers that are water-soluble at specific temperature, and a composition carried by the support comprising exfoliating agent in the form of particles | |
FR2867067A1 (en) | Cosmetic article, useful as e.g. hair capillary composition and make up removal composition, comprises an impregnated substrate of aqueous liquid cosmetic composition, comprising at least a first and second group of fibers | |
EP2497455A2 (en) | Cosmetic device comprising discrete elements | |
FR2897777A1 (en) | Single use cosmetic article, useful to clean/care keratinous matters, particularly hair and/or scalp, comprises water-insoluble substrate impregnated in lotion having water, alcohol, and ester of fatty acid and oxyalkylenated sorbitan | |
WO2009138706A2 (en) | Compositions based on porous polymer/hydrogen peroxide complexes and uses thereof | |
FR2953717A1 (en) | Cosmetic article, useful for e.g. skin care, comprises water insoluble substrate comprising one or more layers, and composition added to or impregnated onto the substrate, in oil-in-water emulsion form comprising thickening polymer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060113 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK YU |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK YU |
|
17Q | First examination report despatched |
Effective date: 20061207 |
|
AKX | Designation fees paid |
Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61Q 9/02 20060101ALI20151123BHEP Ipc: A61K 8/02 20060101AFI20151123BHEP Ipc: A61Q 5/12 20060101ALI20151123BHEP Ipc: A61Q 19/10 20060101ALI20151123BHEP Ipc: A61Q 15/00 20060101ALI20151123BHEP Ipc: A61K 8/81 20060101ALI20151123BHEP Ipc: A61Q 19/00 20060101ALI20151123BHEP Ipc: A61Q 1/02 20060101ALI20151123BHEP Ipc: A61Q 1/14 20060101ALI20151123BHEP |
|
INTG | Intention to grant announced |
Effective date: 20151208 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 793967 Country of ref document: AT Kind code of ref document: T Effective date: 20160515 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: FRENCH |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602005049150 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20160427 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2581956 Country of ref document: ES Kind code of ref document: T3 Effective date: 20160908 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 793967 Country of ref document: AT Kind code of ref document: T Effective date: 20160427 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160728 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160829 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602005049150 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20170130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161231 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161231 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161223 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161231 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 13 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161223 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20161231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20051223 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160427 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20230110 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20231102 Year of fee payment: 19 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20231110 Year of fee payment: 19 Ref country code: FR Payment date: 20231108 Year of fee payment: 19 Ref country code: DE Payment date: 20231031 Year of fee payment: 19 |